1976L0768 — EN — 13.09.2005 — 013.001

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

►B COUNCIL DIRECTIVE of 27 July 1976 on the approximation of the laws of the Member States relating to cosmetic products (76/768/EEC) (OJ L 262, 27.9.1976, p.169)

Amended by:





Amended by:





Corrected by:









▼B

COUNCIL DIRECTIVE

of 27 July 1976

on the approximation of the laws of the Member States relating to cosmetic products

(76/768/EEC)







THE COUNCIL OF THE EUROPEAN COMMUNITIES, Having regard to the Treaty establishing the European Economic Community, and in particular Article 100 thereof, Having regard to the proposal from the Commission, Having regard to the opinion of the European Parliament ( 1 ), Having regard to the opinion of the Economic and Social Committee ( 2 ), Whereas the provisions laid down by law, regulation or administrative action in force in the Member States define the composition characteristics to which cosmetic products must conform and prescribe rules for their labelling and for their packaging; whereas these provisions differ from one Member State to another; Whereas the differences between these laws oblige Community cosmetic producers to vary their production according to the Member State for which the products are intended; whereas, consequently, they hinder trade in these products and, as a result, have a direct effect on the establishment and functioning of the common market; Whereas the main objective of these laws is the safeguarding of public health and whereas, as a result, the pursuit of the same objective must inspire Community legislation in this sector; whereas, however, this objective must be attained by means which also take account of economic and technological requirements; Whereas it is necessary to determine at Community level the regulations which must be observed as regards the composition, labelling and packaging of cosmetic products; Whereas this Directive relates only to cosmetic products and not to pharmaceutical specialities and medicinal products; whereas for this purpose it is necessary to define the scope of the Directive by delimiting the field of cosmetics from that of pharmaceuticals; whereas this delimitation follows in particular from the detailed definition of cosmetic products, which refers both to their areas of application and to the purposes of their use; whereas this Directive is not applicable to the products that fall under the definition of cosmetic product but are exclusively intended to protect from disease; whereas, moreover, it is advisable to specify that certain products come under this definition, whilst products containing substances or preparations intended to be ingested, inhaled, injected or implanted in the human body do not come under the field of cosmetics; Whereas in the present state of research, it is advisable to exclude cosmetic products containing one of the substances listed in Annex V from the scope of this Directive; Whereas cosmetic products must not be harmful under normal or foreseeable conditions of use; whereas in particular it is necessary to take into account the possibility of danger to zones of the body that are contiguous to the area of application; Whereas, in particular, the determination of the methods of analysis together with possible modifications or additions which may have to be made to them on the basis of the results of scientific and technical research, are implementing measures of a technical nature; whereas it is advisable to entrust their adoption to the Commission, subject to certain conditions specified in this Directive, for the purpose of simplifying and accelerating the procedure; Whereas technical progress necessitates rapid adaptation of the technical provisions defined in this Directive and in subsequent Directives in this field; whereas it is advisable, in order to facilitate implementation of the measures necessary for this purpose, to provide for a procedure establishing close cooperation between the Member States and the Commission within the Committee for adaptation to technical progress of Directives aimed at the removal of technical obstacles to trade in the cosmetic products sector; Whereas it is necessary, on the basis of scientific and technical research, to draw up proposals for lists of authorized substances which could include antioxidants, hair dyes, preservatives and ultraviolet filters, taking into account in particular the problem of sensitization; Whereas it could happen that although conforming to the provisions of this Directive and its Annexes, cosmetic products placed on the market might endanger public health; whereas it is therefore advisable to provide for a procedure intended to remove this danger, HAS ADOPTED THIS DIRECTIVE:







Article 1

▼M21

1. A ‘cosmetic product’ shall mean any substance or preparation intended to be placed in contact with the various external parts of the human body (epidermis, hair system, nails, lips and external genital organs) or with the teeth and the mucous membranes of the oral cavity with a view exclusively or mainly to cleaning them, perfuming them, changing their appearance and/or correcting body odours and/or protecting them or keeping them in good condition.

▼B

2. The products to be considered as cosmetic products within the meaning of this definition are listed in Annex I.

▼M14

3. Cosmetic products containing one of the substances listed in Annex V shall be excluded from the scope of this Directive. Member States may take such measures as they deem necessary with regard to those products.

▼M21

Article 2

A cosmetic product put on the market within the Community must not cause damage to human health when applied under normal or reasonably foreseeable conditions of use, taking account, in particular, of the product's presentation, its labelling, any instructions for its use and disposal as well as any other indication or information provided by the manufacturer or his authorized agent or by any other person responsible for placing the product on the Community market.

The provision of such warnings shall not, in any event, exempt any person from compliance with the other requirements laid down in this Directive.

▼B

Article 3

Member States shall take all necessary measures to ensure that only cosmetic products which conform to the provisions of this Directive and its Annexes may be put on the market.

▼M3

Article 4

1. Without prejudice to their general obligations deriving from Article 2, Member States shall prohibit the marketing of cosmetic products containing:

(a) substances listed in Annex II;

(b) substances listed in the first part of Annex III, beyond the limits and outside the conditions laid down;

▼M14

(c) colouring agents other than those listed in Annex IV, Part 1, with the exception of cosmetic products containing colouring agents intended solely to colour hair;

(d) colouring agents listed in Annex IV, Part 1, used outside the conditions laid down, with the exception of cosmetic products containing colouring agents intended solely to colour hair;

▼M3

(e) preservatives other than those listed in Annex VI, Part 1;

(f) preservatives listed in Annex VI, Part 1, beyond the limits and outside the conditions laid down, unless other concentrations are used for specific purposes apparent from the presentation of the product;

▼M7

(g) UV filters other than those listed in Part 1 of Annex VII;

(h) UV filters listed in Part 1 of Annex VII, beyond the limits and outside the conditions laid down therein.

▼M37 —————

▼M3

2. The presence of traces of the substances listed in Annex II shall be allowed provided that such presence is technically unavoidable in good manufacturing practice and that it conforms with Article 2.

▼M37

Article 4a

1. Without prejudice to the general obligations deriving from Article 2, Member States shall prohibit:

(a) the marketing of cosmetic products where the final formulation, in order to meet the requirements of this Directive, has been the subject of animal testing using a method other than an alternative method after such alternative method has been validated and adopted at Community level with due regard to the development of validation within the OECD;

(b) the marketing of cosmetic products containing ingredients or combinations of ingredients which, in order to meet the requirements of this Directive, have been the subject of animal testing using a method other than an alternative method after such alternative method has been validated and adopted at Community level with due regard to the development of validation within the OECD;

(c) the performance on their territory of animal testing of finished cosmetic products in order to meet the requirements of this Directive;

(d) the performance on their territory of animal testing of ingredients or combinations of ingredients in order to meet the requirements of this Directive, no later than the date on which such tests are required to be replaced by one or more validated alternative methods listed in Annex V to Council Directive 67/548/EEC of 27 June 1967 on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances ( 3 )or in Annex IX to this Directive.

No later than 11 September 2004 the Commission shall, in accordance with the procedure referred to in Article 10(2) and after consultation of the Scientific Committee on Cosmetic Products and Non-Food Products intended for consumers (SCCNFP) establish the contents of Annex IX.

2. The Commission, after consultation of the SCCNFP and of the European Centre for the Validation of Alternative Methods (ECVAM) and with due regard to the development of validation within the OECD, shall establish timetables for the implementation of the provisions under paragraph 1(a), (b) and (d), including deadlines for the phasing-out of the various tests. The timetables shall be made available to the public not later than 11 September 2004 and be sent to the European Parliament and the Council. The period for implementation shall be limited to a maximum of six years after the entry into force of Directive 2003/15/EC in relation to paragraph 1(a), (b) and (d).

(2.1) In relation to the tests concerning repeated-dose toxicity, reproductive toxicity and toxicokinetics, for which there are no alternatives yet under consideration, the period for implementation of paragraph 1(a) and (b) shall be limited to a maximum of 10 years after the entry into force of Directive 2003/15/EC.

(2.2) The Commission shall study possible technical difficulties in complying with the ban in relation to tests, in particular those concerning repeated-dose toxicity, reproductive toxicity and toxicokinetics, for which there are no alternatives yet under consideration. Information about the provisional and final results of these studies should form part of the yearly reports presented pursuant to Article 9.

On the basis of these annual reports, the timetables established in accordance with paragraph 2 may be adapted within a maximum time limit of six years as referred to in paragraph 2 or 10 years as referred to in paragraph 2.1 and after consultation of the entities referred to in paragraph 2.

(2.3) The Commission shall study progress and compliance with the deadlines as well as possible technical difficulties in complying with the ban. Information about the provisional and final results of the Commission studies should form part of the yearly reports presented pursuant to Article 9. If these studies conclude, at the latest two years prior to the end of the maximum period referred to in paragraph 2.1, that for technical reasons one or more tests referred to in paragraph 2.1 will not be developed and validated before the expiry of the period referred to in paragraph 2.1 it shall inform the European Parliament and the Council and shall put forward a legislative proposal in accordance with Article 251 of the Treaty.

(2.4) In exceptional circumstances where serious concerns arise as regards the safety of an existing cosmetic ingredient a Member State may request the Commission to grant a derogation from paragraph 1. The request shall contain an evaluation of the situation and indicate the measures necessary. On this basis, the Commission may, after consultation of the SCCNFP and by means of a reasoned decision, authorise the derogation in accordance with the procedure referred to in Article 10(2). This authorisation shall lay down the conditions associated with this derogation in terms of specific objectives, duration and reporting of the results.

A derogation shall only be granted if:

(a) the ingredient is in wide use and cannot be replaced by another ingredient able to perform a similar function;

(b) the specific human health problem is substantiated and the need to conduct animal tests is justified and is supported by a detailed research Protocol proposed as the basis for the evaluation.

The decision on the authorisation, the conditions associated with it and the final result achieved shall be part of the annual report to be presented by the Commission in accordance with Article 9.

3. For the purposes of this Article:

(a) ‘finished cosmetic product’ means the cosmetic product in its final formulation, as placed on the market and made available to the final consumer, or its prototype.

(b) ‘prototype’ means a first model or design that has not been produced in batches, and from which the finished cosmetic product is copied or finally developed.

Article 4b

The use in cosmetic products of substances classified as carcinogenic, mutagenic or toxic for reproduction, of category 1, 2 and 3, under Annex I to Directive 67/548/EEC shall be prohibited. To that end the Commission shall adopt the necessary measures in accordance with the procedure referred to in Article 10(2). A substance classified in category 3 may be used in cosmetics if the substance has been evaluated by the SCCNFP and found acceptable for use in cosmetic products.

▼M14

Article 5

Member States shall allow the marketing of cosmetic products containing:

(a) the substances listed in Annex III, Part 2, within the limits and under the conditions laid down, up to the dates in column (g) of that Annex;

(b) the colouring agents listed in Annex IV, Part 2, within the limits and under the conditions laid down, until the admission dates given in that Annex;

(c) the preservatives listed in Annex VI, Part 2, within the limits and under the condition laid down, until the dates given in column (f) of that Annex. However, some of these substances may be used in other concentrations for specific purposes apparent from the presentation of the product;

(d) the UV filters listed in Part 2 of Annex VII, within the limits and under the conditions laid down, until the dates given in column (f) of that Annex.

At these dates, these substances, colouring agents, preservatives and UV filters shall be:

— definitively allowed, or

— definitively prohibited (Annex II), or

— maintained for a given period specified in Part 2 of Annexes III, IV, VI and VII, or

— deleted from all the Annexes, on the basis of available scientific information or because they are no longer used.

▼M21

Article 5a

1. No later than 14 December 1994 the Commission shall, under the procedure laid down in Article 10, compile an inventory of ingredients employed in cosmetic products, on the basis in particular of information supplied by the industry concerned.

For the purposes of this Article, ‘cosmetic ingredient’ shall mean any chemical substance or preparation of synthetic or natural origin, except for perfume and aromatic compositions, used in the composition of cosmetic products.

The inventory shall be divided into two sections: one concerning perfume and aromatic raw materials and the second concerning other substances.

2. The inventory shall contain informtion on:

— the identity of each ingredient, in particular its chemical name, the CTFA name, the European Pharmacopoeia name, the international non-proprietary names recommended by the World Health Organization, the Einecs, Iupac, CAS and colour index numbers, and the common name referred to in Article 7 (2),

— the usual function(s) of the ingredient in the final product,

— where appropriate, restrictions and conditions of use and warnings which must be printed on the label by reference to the Annexes.

3. The Commission shall publish the inventory and shall update it periodically under the procedure provided for in Article 10. The inventory shall be indicative and shall not constitute a list of the substances authorized for use in cosmetic products.

▼M14

Article 6

▼M21

1. Member States shall take all measures necessary to ensure that cosmetic products may be marketed only if the container and packaging bear the following information in indelible, easily legible and visible lettering; the information mentioned in point (g) may, however, be indicated on the packaging alone:

▼M14

(a) the name or style and the address or registered office of the manufacturer or the person responsible for marketing the cosmetic product who is established within the Community. Such information may be abbreviated in so far as the abbreviation makes it generally possible to identify the undertaking. Member States may require that the country of origin be specified for goods manufactured outside the Community;

b) the nominal content at the time of packaging, given by weight or by volume, except in the case of packaging containing less than five grams or five millilitres, free samples and single-application packs; for pre-packages normally sold as a number of items, for which details of weight or volume are not significant, the content need not be given provided the number of items appears on the packaging. This information need not be given if the number of items is easy to see from the outside or if the product is normally only sold individually;

▼M37

(c) the date of minimum durability shall be indicated by the words: ‘best used before the end of’ followed by either: — the date itself, or — details of where it appears on the packaging. The date shall be clearly expressed and shall consist of either the month and year or the day, month and year in that order. If necessary, this information shall be supplemented by an indication of the conditions which must be satisfied to guarantee the stated durability. Indication of the date of durability shall not be mandatory for cosmetic products with a minimum durability of more than 30 months. For such products, there shall be an indication of the period of time after opening for which the product can be used without any harm to the consumer. This information shall be indicated by the symbol given in Annex VIIIa followed by the period (in months and/or years);

▼M21

(d) particular precautions to be observed in use, especially those listed in the column ‘Conditions of use and warnings which must be printed on the label’ in Annexes III, IV, VI and VII, which must appear on the container and packaging, as well as any special precautionary information on cosmetic products for professional use, in particular in hairdressing. Where this is impossible for practical reasons, an enclosed leaflet, label, tape or card must contain that information to which the consumer is referred either by abbreviated information or the symbol given in Annex VIII, which must appear on the container and the packaging;

▼M14

(e) the batch number of manufacture or the reference for identifying the goods. Where this is impossible for practical reasons because the cosmetic products are too small, such information need appear only on the packaging;

▼M21

(f) the function of the product, unless it is clear from the presentation of the product;

▼M37

(g) a list of ingredients in descending order of weight at the time they are added. That list shall be preceded by the word ‘ingredients’. Where that is impossible for practical reasons, an enclosed leaflet, label, tape or card must contain the ingredients to which the consumer is referred either by abbreviated information or the symbol given in Annex VIII, which must appear on the packaging. The following shall not, however, be regarded as ingredients: — impurities in the raw materials used, — subsidiary technical materials used in the preparation but not present in the final product, — materials used in strictly necessary quantities as solvents or as carriers for perfume and aromatic compositions. Perfume and aromatic compositions and their raw materials shall be referred to by the word ‘perfume’ or ‘aroma’. However, the presence of substances, the mention of which is required under the column ‘other limitations and requirements’ in Annex III, shall be indicated in the list irrespective of their function in the product. Ingredients in concentrations of less than 1 % may be listed in any order after those in concentrations of more than 1 %. Colouring agents may be listed in any order after the other ingredients, in accordance with the colour index number or denomination adopted in Annex IV. For decorative cosmetic products marketed in several colour shades, all colouring agents used in the range may be listed, provided that the words ‘may contain’ or the symbol ‘+/-’ are added. An ingredient must be identified by the common name referred to in Article 7(2) or, failing that, by one of the names referred to in Article 5a(2), first indent. In accordance with the procedure referred to in Article 10(2), the Commission may adapt the criteria and conditions set out in Commission Directive 95/17/EC of 19 June 1995 laying down detailed rules for the application of Council Directive 76/768/EEC as regards the non-inclusion of one or more ingredients on the list used for the labelling of cosmetic products ( 4 ) under which a manufacturer may, for reasons of trade secrecy, apply not to include one or more ingredients on the abovementioned list.

▼M21

Where it is impracticable, for reasons of size or shape, for the particulars referred to in points (d) and (g) to appear in an enclosed leaflet, those particulars shall appear on a label, tape or card which is enclosed or attached to the cosmetic product.

In the case of soap, bath balls and other small products where it is impraticable, for reasons of size or shape, for the particulars referred to in point (g) to appear on a label, tag, tape or card or in an enclosed leaflet, those particulars shall appear on a notice in immediate proximity to the container in which the cosmetic product is exposed for sale.

▼M14

2. For cosmetic products that are not pre-packaged, are packaged at the point of sale at the purchaser's request, or are pre-packaged for immediate sale, Member States shall adopt detailed rules for indication of the particulars referred to in paragraph 1.

3. Member States shall take all measures necessary to ensure that, in the labelling, putting up for sale and advertising of cosmetic products, text, names, trade marks, pictures and figurative or other signs are not used to imply that these products have characteristics which they do not have. ►M37 ————— ◄

▼M37

Furthermore, the manufacturer or the person responsible for placing the product on the Community market may take advantage, on the product packaging or in any document, notice, label, ring or collar accompanying or referring to the product, of the fact that no animal tests have been carried out only if the manufacturer and his suppliers have not carried out or commissioned any animal tests on the finished product, or its prototype, or any of the ingredients contained in it, or used any ingredients that have been tested on animals by others for the purpose of developing new cosmetic products. Guidelines shall be adopted in accordance with the procedure referred to in Article 10(2) and published in the Official Journal of the European Union. The European Parliament shall receive copies of the draft measures submitted to the Committee.

▼B

Article 7

1. Member States may not, for reasons related to the requirements laid down in this Directive and the Annexes thereto, refuse, prohibit or restrict the marketing of any cosmetic products which comply with the requirements of this Directive and the Annexes thereto.

▼M21

2. They may, however, require that the particulars provided for in Article 6 (1) (b), (c), (d) and (f) be expressed at least in their own national or official language or languages; they may also require that the particulars provided for in Article 6 (1) (g) be expressed in a language easily understood by the consumer. To that end, the Commission shall adopt a common ingredients nomenclature in accordance with the Article 10 procedure.

3. Furthermore, a Member State may, for purposes of prompt and appropriate medical treatment in the event of difficulties, require that appropriate and adequate information on substances used in cosmetic products be made available to the competent authority, which shall ensure that that information is used only for the purposes of such treatment.

Each Member State shall designate a competent authority and send details thereof to the Commission, which shall publish that information in the Official Journal of the European Communities.

Article 7a

1. The manufacturer or his agent or the person to whose order a cosmetic product is manufactured or the person responsible for placing an imported cosmetic product on the Community market shall for control purposes keep the following information readily accessible to the competent authorities of the Member State concerned at the address specified on the label in accordance with Article 6 (1) (a):

(a) the qualitative and quantitative composition of the product; in the case of perfume compositions and perfumes, the name and code number of the composition and the identity of the supplier;

(b) the physico-chemical and microbiological specifications of the raw materials and the finished product and the purity and microbiological control criteria of the cosmetic product;

(c) the method of manufacture complying with the good manufacturing practice laid down by Community law or, failing that, laid down by the law of the Member State concerned; the person responsible for manufacture or first importation into the Community must possess an appropriate level of professional qualification or experience in accordance with the legislation and practice of the Member State which is the place of manufacture or first importation;

▼M37

(d) assessment of the safety for human health of the finished product. To that end the manufacturer shall take into consideration the general toxicological profile of the ingredients, their chemical structure and their level of exposure. It shall take particular account of the specific exposure characteristics of the areas on which the product will be applied or of the population for which it is intended. There shall be inter alia a specific assessment for cosmetic products intended for use on children under the age of three and for cosmetic products intended exclusively for use in external intimate hygiene. Should the same product be manufactured at several places within Community territory, the manufacturer may choose a single place of manufacture where that information will be available. In this connection, and when so requested for monitoring purposes, it shall be obliged to indicate the place so chosen to the monitoring authority or authorities concerned. In this case this information shall be easily accessible;

▼M21

(e) the name and address of the qualified person or persons responsible for the assessment referred to in (d). That person must hold a diploma as defined in Article 1 of Directive 89/48/EEC in the field of pharmacy, toxicology, dermatology, medicine or a similar discipline;

(f) existing data on undesirable effects on human health resulting from use of the cosmetic product;

(g) proof of the effect claimed for the cosmetic product, where justified by the nature of the effect or product;

▼M37

(h) data on any animal testing performed by the manufacturer, his agents or suppliers, relating to the development or safety evaluation of the product or its ingredients, including any animal testing performed to meet the legislative or regulatory requirements of non-member countries. Without prejudice to the protection, in particular, of commercial secrecy and of intellectual property rights, Member States shall ensure that the information required under (a) and (f) shall be made easily accessible to the public by any appropriate means, including electronic means. The quantitative information required under (a) to be made publicly accessible shall be limited to dangerous substances covered by Directive 67/548/EEC.

▼M21

2. The assessment of the safety for human health referred to in paragraph 1 (d) shall be carried out in accordance with the principle of good laboratory practice laid down in Council Directive 87/18/EEC of 18 December 1986 on the harmonization of laws, regulations and administrative provisions relating to the application of the principles of good laboratory practice and the verification of their application for tests on chemical substances ( 5 ).

3. The information referred to in paragraph 1 must be available in the national language or languages of the Member State concerned, or in a language readily understood by the competent authorities.

4. The manufacturer or his agent, or the person to whose order a cosmetic product is manufactured, or the person responsible for placing imported cosmetic products on the Community market, shall notify the competent authority of the Member State of the place of manufacture or of the initial importation of the address of the place of manufacture or of initial importation into the Community of the cosmetic products before the latter are placed on the Community market.

5. Member States shall designate the competent authorities referred to in paragraphs 1 and 4 and shall send details thereof to the Commission, which shall publish that information in the Official Journal of the European Communities.

The Member States shall ensure that the abovementioned authorities continue to cooperate in areas where such cooperation is necessary to the smooth application of this Directive.

▼M3

Article 8

1. In accordance with the procedure laid down in Article 10 the following shall be determined:

— the methods of analysis necessary for checking the composition of cosmetic products,

— the criteria of microbiological and chemical purity for cosmetic products and methods for checking compliance with those criteria.

▼M21

2. The common nomenclature of ingredients used in cosmetic products and, after consultation of the ►M37 Scientific Committee for Cosmetic Products and Non-Food Products intended for Consumers ◄ , the amendments necessary for the adaptation to technical progress of the Annexes shall be adopted in accordance with the same procedure, as appropriate.

▼M3

Article 8a

1. Notwithstanding Article 4 and without prejudice to Article 8 (2), a Member State may authorize the use within its territory of other substances not contained in the lists of substances allowed, for certain cosmetic products specified in its national authorization, subject to the following conditions:

(a) the authorization must be limited to a maximum period of three years;

(b) the Member State must carry out an official check on cosmetic products manufactured from the substance or preparation use of which it has authorized;

(c) cosmetic products thus manufactured must bear a distinctive indication which will be defined in the authorization.

2. The Member Stats shall forward to the Commission and to the other Member States the next of any authorization decision taken pursuant to paragraph 1 within two months of the date on which it came into effect.

3. Before expiry of the three-year period provided for in paragraph 1, the Member State may submit to the Commission a request for the inclusion in a list of permitted substances of the substance given national authorization in accordance with paragraph 1. At the same time, it shall supply supporting documents setting out the grounds on which it deems such inclusion justified and shall indicate the uses for which the substance or preparation is intended. Within 18 months of submission of the request, a decision shall be taken on the basis of the latest scientific and technical knowledge, after consultation, at the initiative of the Commission or of a Member State, of the ►M37 Scientific Committee for Cosmetic Products and Non-Food Products intended for Consumers ◄ and in accordance with the procedure laid down in Article 10 as to whether the substance in question may be included in a list of permitted substances or whether the national authorization should be revoked. Notwithstanding paragraph 1 (a), the national authorization shall remain in force until a decision is taken on the request for inclusion in the list.

▼M37

Article 9

Every year the Commission shall present a report to the European Parliament and the Council on:

(a) progress made in the development, validation and legal acceptance of alternative methods. The report shall contain precise data on the number and type of experiments relating to cosmetic products carried out on animals. The Member States shall be obliged to collect that information in addition to collecting statistics as laid down by Council Directive 86/609/EEC of 24 November 1986 on the approximation of laws, regulations and administrative provisions of the Member States regarding the protection of animals used for experimental and other scientific purposes ( 6 ). The Commission shall in particular ensure the development, validation and legal acceptance of alternative test methods which do not use live animals;

(b) progress made by the Commission in its efforts to obtain acceptance by the OECD of alternative methods validated at Community level and recognition by non-member countries of the results of the safety tests carried out in the Community using alternative methods, in particular within the framework of cooperation agreements between the Community and these countries;

(c) the manner in which the specific needs of small and medium-sized enterprises have been taken into account.

Article 10

1. The Commission shall be assisted by the Standing Committee on Cosmetic Products.

2. Where reference is made to this paragraph, Articles 5 and 7 of Decision 1999/468/EC shall apply, having regard to the provisions of Article 8 thereof.

The period laid down in Article 5(6) of Decision 1999/468/EC shall be set at three months.

3. The Committee shall adopt its rules of procedure.

▼B

Article 11

Without prejudice to Article 5 and not later than one year after expiry of the period laid down in Article 14 (1) for implementation of this Directive by the Member States, the Commission shall, on the basis of the results of the latest scientific and technical research, submit to the Council appropriate proposals establishing lists of permitted substances.

Article 12

1. If a Member State notes, on the basis of a substantiated justification, that a cosmetic product, although complying with the requirements of the Directive, represents a hazard to health, it may provisionally prohibit the marketing of that product in its territory or subject it to special conditions. It shall immediately inform the other Member States and the Commission thereof, stating the grounds for its decision.

▼M14

2. The Commission shall as soon as possible consult the Member States concerned, following which it shall deliver its opinion without delay and take the appropriate steps.

▼B

3. If the Commission is of the opinion that technical adaptations to the Directive are necessary, such adaptations shall be adopted by either the Commission or the Council in accordance with the procedure laid down in Article 10. In that event, the Member State which has adopted safeguard measures may maintain them until entry into force of the adaptations.

Article 13

Precise reasons shall be stated for any individual measures placing a restriction or ban on the marketing of cosmetic products taken pursuant to this Directive. It shall be notified to the party concerned together with particulars of the remedies available to him under the laws in force in the Member States and of the time limits allowed for the exercise of such remedies.

Article 14

1. Member States shall bring into force the provisions needed in order to comply with this Directive within 18 months of its notification and shall forthwith inform the Commission thereof.

2. Member States may, however, for a period of 36 months from notification of this Directive, authorize the marketing in their territory of cosmetic products which do not conform to the requirements of the Directive.

3. Member States shall ensure that the texts of such provisions of national law as they adopt in the field governed by this Directive are communicated to the Commission.

Article 15

This Directive is addressed to the Member States.









ANNEX I

ILLUSTRATIVE LIST BY CATEGORY OF COSMETIC PRODUCTS

— Creams, emulsions, lotions, gels and oils for the skin (hands, face, feet, etc.).

— Face masks (with the exception of peeling products).

— Tinted bases (liquids, pastes, powders).

— Make-up powders, after-bath powders, hygienic powders, etc.

— Toilet soaps, deodorant soaps, etc.

— Perfumes, toilet waters and eau de Cologne.

— Bath and shower preparations (salts, foams, oils, gels, etc.).

— Depilatories.

— Deodorants and anti-perspirants.

— Hair care products: — — hair tints and bleaches, — products for waving, straightening and fixing, — setting products, — cleansing products (lotions, powders, shampoos), — conditioning products (lotions, creams, oils), — hairdressing products (lotions, lacquers, brilliantines).

— Shaving products (creams, foams, lotions, etc.).

— Products for making up and removing make-up from the face and the eyes.

— Products intended for application to the lips.

— Products for care of the teeth and the mouth.

— Products for nail care and make-up.

— Products for external intimate hygiene.

— Sunbathing products.

— Products for tanning without sun.

— Skin-whitening products.

— Anti-wrinkle products.









ANNEX II

▼M3

LIST OF SUBSTANCES WHICH MUST NOT FORM PART OF THE COMPOSITION OF COSMETIC PRODUCTS

▼B

1. N-5-Chlorobenzoxazol-2-ylacetamide

2. ►M3 2-Acetoxyethyltrimethylammonium hydroxide (acetylcholine) and its salts ◄

3. Deanol aceglumate ( 7 )

4. Spironolactone*

5. ►M3 [4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl]acetic acid and its salts ◄

6. Methotrexate*

7. Aminocaproic acid* and its salts

8. Cinchophen*, its salts, derivatives and salts of these derivatives

9. Thyropropic acid* and its salts

10. Trichloroacetic acid

11. Aconitum napellus L. (leaves, roots and galenical preparations)

12. Aconitine (principal alkaloid of Aconitum napellus L.) and its salts

13. Adonis vernalis L. and its preparations

14. Epinephrine*

15. Rauwolfia serpentina alkaloids and their salts

16. Alkyne alcohols, their esters, ethers and salts

17. Isoprenaline*

18. Allyl isothiocyanate

19. Alloclamide* and its salts

20. Nalorphine*, its salts and ethers

21. Sympathicomimetic amines acting on the central nervous system: any substance contained in the first list of medicaments which are subject to medical prescription and are referred to in resolution AP (69) 2 of the Council of Europe

22. Aniline, its salts and its halogenated and sulphonated derivatives

23. Betoxycaine* and its salts

24. Zoxazolamine*

25. Procainamide*, its salts and derivatives

26. Benzidine

27. Tuaminoheptane*, its isomers and salts

28. Octodrine* and its salts

29. ►M3 2-Amino-1,2-bis(4-methoxyphenyl)ethanol and its salts ◄

30. 1,3-dimethylpentylamine and its salts

31. 4-Aminosalicylic acid and its salts

32. Toluidines, their isomers, salts and halogenated and sulphonated derivatives

33. Xylidines, their isomers, salts and halogenated and sulphonated derivatives

35. Ammi majus and its galenical preparations

36. 2,3-Dichloro-2-methylbutane

37. Substances with androgenic effect

38. Anthracene oil

40. Antimony and its compounds

41. Apocynum cannabinum L. and its preparations

42. ►M3 Apomorphine (R 5,6,6a, 7-tetrahydro-6-methyl-4H-dibenzo [de,g]quinoline-10,11-diol) and its salts ◄

43. Arsenic and its compounds

44. Atropa belladonna L. and its preparations

45. Atropine, its salts and derivatives

▼M4

46. Barium salts, with the exception of barium sulphate, barium sulphide under the conditions laid down in Annex III, Part 1, and lakes, salts and pigments prepared from the colouring agents listed with the reference (5) in Annex III, Part 2 and Annex IV, Part 2.

▼B

47. Benzene

49. ►M3 Benzazepines and benzodiazepines ◄

50. ►M3 1-Dimethylaminomethyl-1-methylpropyl benzoate (amylocaine) and its salts ◄

51. ►M3 2,2,6-Trimethyl-4-piperidyl benzoate (benzamine) and its salts ◄

53. Bendroflumethiazide* and its derivatives

54. Beryllium and its compounds

55. Bromine, elemental

56. Bretylium tosilate*

57. Carbromal*

58. Bromisoval*

59. Brompheniramine* and its salts

60. Benzilonium bromide*

61. Tetrylammonium bromide*

62. Brucine

63. Tetracaine* and its salts

64. Mofebutazone*

65. Tolbutamide*

66. Carbutamide*

67. Phenylbutazone*

68. Cadmium and its compounds

69. Cantharides, Cantharis vesicatoria

70. (1R,2S)-Hexahydro-1,2-dimethyl-3,6-epoxyphthalic anhydride (cantharidin)

71. Phenprobamate*

72. ►M3 Nitroderivatives of carbazole ◄

73. Carbon disulphide

74. Catalase

75. Cephaeline and its salts

76. Chenopodium ambrosioides (essential oil)

77. 2,2,2-Trichloroethane-1,1-diol

78. Chlorine

79. Chlorpropamide*

81. 4-Phenylazophenylene-1,3-diamine citrate hydrochloride (chrysoidine citrate hydrochloride)

82. Chlorzoxazone*

83. 2-Chloro-6-methylpyrimidin-4-yldimethylamine (crimidine-ISO)

84. Chlorprothixene* and its salts

85. Clofenamide*

86. ►M3 N,N-bis(2-chloroethyl)methylamine N-oxide and its salts ◄

87. Chlormethine* and its salts

88. Cyclophosphamide* and its salts

89. Mannomustine* and its salts

90. Butanilicaine* and its salts

92. Triparanol*

93. 2-[2(4-Chiorophenyl)-2-phenylacetyl] indane-1,3-dione (chlorophacinone-ISO)

94. Chlorphenoxamine*

96. Chloroethane

97. Chromium; chromic acid and its salts

98. Claviceps purpurea Tul., its alkaloids and galenical preparations

99. Conium maculatum L. (fruit, powder, galenical preparations)

100. Glycyclamide*

101. Cobalt benzenesulphonate

102. Colchicine, its salts and derivatives

103. Colchicoside and its derivatives

104. Golchicum autumnale L. and its galenical preparations

105. Convallatoxin

106. Anamirta cocculus L. (fruit)

107. Croton tiglium (oil)

108. 1-Butyl-3-(N-crotonoylsulphanilyl)urea

109. Curare and curarine

110. Synthetic curarizants

111. Hydrogen cyanide and its salts

113. Cyclomenol* and its salts

114. Sodium hexacyclonate*

115. Hexapropymate*

116. Dextropropoxyphene*

118. Pipazetate* and its salts

122. Cyclarbamate*

123. Clofenotane*; DDT (ISO)

125. Dichloroethanes (ethylene chlorides)

126. Dichloroethylenes (acetylene chlorides)

127. Lysergide* and its salts

128. ►M3 2-Diethylaminoethyl-3-hydroxy-4-phenylbenzoate and its salts ◄

129. Cinchocaine* and its salts

130. 3-Diethylaminopropyl cinnamate

133. Methyprylon* and its salts

134. Digitaline and all heterosides of Digitalis purpurea L.

135. 7-[2-Hydroxy-3-(2-hydroxyethyl-N-methylamino)propyl]theophylline (xanthinol)

136. Dioxethedrin* and its salts

137. Piprocurarium*

138. Propyphenazone*

139. Tetrabenazine* and its salts

140. Captodiame*

141. Mefeclorazine* and its salts

142. Dimethylamine

143. ►M3 1,1-Bis(dimethylaminomethyl)propyl benzoate (amydricaine, alypine) and its salts ◄

144. Methapyrilene* and its salts

145. Metamfepramone* and its salts

146. Amitriptyline* and its salts

147. Metformin* and its salts

148. Isosorbide dinitrate*

149. Malononitrile

150. Succinonitrile

151. Dinitrophenol isomers

152. Inproquone*

153. Dimevamide* and its salts

154. Diphenylpyraline* and its salts

155. Sulfinpyrazone*

157. Benactyzine*

158. Benzatropine* and its salts

159. Cyclizine* and its salts

161. Probenecid*

162. Disulfiram*; thiram (ISO)

163. Emetine, its salts and derivatives

164. Ephedrine and its salts

165. Oxanamide* and its derivatives

166. Eserine or physostigmine and its salts

167. Esters of 4-aminobenzoic acid, with the free amino group, with the exception of that given in ►M9 Annex VII, Part 2 ◄

168. Choline salts and their esters, e.g. choline chloride

169. Caramiphen* and its salts

170. Diethyl 4-nitrophenyl phosphate

171. Metethoheptazine* and its salts

172. Oxpheneridine* and its salts

173. Ethoheptazine* and its salts

174. Metheptazine* and its salts

175. Methylphenidate* and its salts

176. Doxylamine* and its salts

177. Tolboxane*

▼C7

178. 4-Benzyloxyphenol and 4-ethoxyphenol

▼B

179. Parethoxycaine* and its salts

180. Fenozolone*

181. Glutethimide* and its salts

182. Ethylene oxide

183. Bemegride* and its salts

184. Valnoctamide*

185. Haloperidol*

186. Paramethasone*

187. Fluanisone*

188. Trifluperidol*

189. Fluoresone*

190. Fluorouracil*

▼M3

191. Hydrofluoric acid, its normal salts, its complexes and hydrofluorides with the exception of those given in Annex III, Part 1

▼B

192. Furfuryltrimethylammonium salts, e.g. furtrethonium iodide*

193. Galantamine*

195. 1,2,3,4,5,6-Hexachlorocyclohexane (BHC-ISO)

197. Hexachloroethane

198. (1R,4S,5R,8S)-1,2,3,4,10,10-Hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethano-naphthalene (isodrin-ISO)

199. Hydrastine, hydrastinine and their salts

200. Hydrazides and their salts

201. Hydrazine, its derivatives and their salts

202. Octamoxin* and its salts

203. Warfarin* and its salts

204. ►M3 Ethyl bis(4-hydroxy-2-oxo-1-benzopyran-3-yl) acetate and salts of the acid ◄

205. Methocarbamol*

206. Propatylnitrate*

208. Fenadiazole*

209. Nitroxoline* and its salts

210. Hyoscyamine, its salts and derivatives

211. Hyoscyamus niger L. (leaves, seeds, powder and galenical preparations)

212. Pemoline* and its salts

213. Iodine

214. ►M3 Decamethylenebis(trimethylammonium) salts, e.g. decamethonium bromide ◄

215. Ipecacuanha (Cephaelis ipecacuanha Brot. and related species) (roots, powder and galenical preparations)

216. (2-Isopropylpent.4-enoyl)urea (apronalide)

218. Lobelia inflata L. and its galenical preparations

219. Lobeline* and its salts

220. Barbiturates

▼M11

221. Mercury and its compounds, except those special cases included ►M18 in Annex VI, Part 1 ◄

▼B

222. 3,4,5-Trimethoxyphenethylamine and its salts

223. Metaldehyde

224. 2-(4-Allyl-2-methoxyphenoxy)-N,N-diethylacetamide and its salts

225. Coumetarol*

226. Dextromethorphan* and its salts

227. 2-Methylheptylamine and its salts

228. Isometheptene* and its salts

229. Mecamylamine*

230. Guaifenesin*

231. Dicoumarol*

232. Phenmetrazine*, its derivatives and salts

233. Thiamazole*

235. Carisoprodol*

236. Meprobamate*

237. Tefazoline* and its salts

238. Arecoline

239. Poldine metilsulfate*

240. Hydroxyzine*

241. 2-Naphthol

242. 1-and 2-Naphthylamines and their salts

244. Naphazoline* and its salts

245. Neostigmine and its salts (e.g. neostigmine bromide*)

246. Nicotine and its salts

247. Amyl nitrites

248. Inorganic nitrites, with the exception of sodium nitrite

249. Nitrobenzene

250. Nitrocresols and their alkali metal salts

251. Nitrofurantoin*

252. Furazolidone*

253. Propane-1,2,3-triyl trinitrate

254. Acenocoumarol*

255. Alkali pentacyanonitrosylferrate (2-)

256. Nitrostilbenes, their homologues and their derivatives

257. Noradrenaline and its salts

258. Noscapine* and its salts

159. Guanethidine* and its salts

261. Oleandrin

262. Chlortalidone*

263. Pelletierine and its salts

264. Pentachloroethane

265. Pentaerithrityl tetranitrate*

266. Petrichloral*

267. Octamylamine* and its salts

▼M3

268. Picric acid

▼B

269. Phenacemide*

270. Difendoxazine*

272. Ethylphenacemide*

273. Phenprocoumon*

274. Fenyramidol*

275. Triamterene* and its salts

276. ►M3 Tetraethyl pyrophosphate; TEPP (ISO) ◄

277. Tritolyl phosphate

278. Psilocybine*

279. Phosphorus and metal phosphides

280. Thalidomide* and its salts

281. Physostigma venenosum Balf.

282. Picrotoxin

283. Pilocarpine and its salts

284. ►M3 α-Piperidin-2-ylbenzyl acette (SIC! acetate) laevorotatory threoform (levophacetoperane) and its salts ◄

285. Pipradrol* and its salts

286. Azacyclonol* and its salts

287. Bietamiverine*

288. Butopiprine* and its salts

▼M43

289. Lead and its compounds

▼B

290. Coniine

291. Prunus laurocerasus L. (‘cherry laurel water’)

292. Metyrapone*

▼M34

293. Radioactive substances, as defined by Directive 96/29/Euratom ( 8 ) laying down basic safety standards for the protection of the health of workers and the general public against the dangers arising from ionising radiation.

▼B

294. Juniperus sabina L. (leaves, essential oil and galenical preparations)

295. Hyoscine, its salts and derivatives

296. Gold salts

▼M9

297. Selenium and its compounds with the exception of selenium disulphiele under the conditions set out under reference No 49 in Annex Ill, Part 1

▼B

298. Solanum nigrum L. and its galenical preparations

299. Sparteine and its salts

300. Glucocorticoids

301. Datura stramonium L. and its galenical preparations

302. Strophantines, their aglucones and their respective derivatives

303. Strophantus species and their galenical preparations

304. Strychnine and its salts

305. Strychnos species and their galenical preparations

306. Narcotics, natural and synthetic: All substances listed in Tables I and II of the single Convention on narcotic drugs signed in New York on 30 March 1961

307. ►M3 Sulphonamides (sulphanilamide and its derivatives…) and their salts obtained by substitution of one or more H-atoms of the -NH2 groups) and their salts ◄

308. Sultiame*

309. Neodymium and its salts

310. Thiotepa*

311. Pilocarpus jaborandi Holmes and its galenical preparations

312. Tellurium and its compounds

313. ►M3 Xylometazoline* and its salts ◄

314. Tetrachloroethylene

315. Carbon tetrachloride

316. Hexaethyl tetraphosphate

317. Thallium and its compounds

318. Thevetia neriifolia Juss., glycoside extract

319. Ethionamide*

320. Phenothiazine* and its compounds

▼M3

321. Thiourea and its derivatives, with the exception of the one listed in Annex III, Part 1

▼B

322. Mephenesin* and its esters

323. Vaccines, toxins or serums listed in the Annex to the second Council Directive of 20 May 1975 on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products (OJ No L 147, 9. 6. 1975, p. 13)

324. Tranylcypromine* and its salts

325. Trichloronitromethane (chloropicrine)

326. 2,2,2-Tribromoethanol (tribromoethyl alcohol)

327. Trichiormethine* and its salts

328. Tretamine*

329. Gallamine triethiodide*

330. Urginea scilla Stern. and its galenical preparations

331. Veratrine, its salts and galenical preparations

332. Schoenocaulon olficinale Lind. (seeds and galenical preparations)

▼M8

333. Veratrum Spp. and their preparations

▼B

334. Vinyl chloride monomer

335. Ergocalciferol* and cholecalciferol (vitamins D2 and D3)

336. Salts of O-alkyldithiocarbonic acids

337. Yobimbine and its salts

338. Dimethyl sulfoxide*

339. Diphenhydramine* and its salts

340. 4-tert-Butylphenol

341. 4-tert-Butylpyrocatechol

342. Dihydrotachysterol

343. Dioxane

344. Morpholine and its salts

345. Pyretbrum album L. and its galenical preparations

347. Tripelennamine*

348. Tetrachlorosalicylanilides

349. Dichlorosalicylanilides

▼M3

▼B

352. Bithionol*

353. Thiuram monosulphides

354. Thiuram disulphides

355. Dimethylformamide

356. 4-Phenylbut-3-en-2-one

357. Benzoates of 4-hydroxy-3-methoxycinnamyl alcohol except for normal content in natural essences used

▼M24

358. Furocoumarines (e.g. trioxysalan*, 8-methoxypsoralen, 5-methoxypsoralen) except for normal content in natural essences used. In sun protection and in bronzing products, furocoumarines shall be below 1 mg/kg.

▼B

359. Oil from the seeds of Laurus nobilis L.

▼M3

360. Safrole except for normal content in the natural essences used and provided the concentration does not exceed: 100 ppm in the finished product, 50 ppm in products for dental and oral hygiene, and provided that Safrole is not present in toothpastes intended specifically for children

▼B

361. 5,5'-Di-isopropyl-2,2'-dimethylbiphenyl-4,4'-diyl dihypoiodite

▼M32 —————

▼M32

362. 3'-Ethyl-5',6',7',8'-tetrahydro-5',5',8',8'-tetramethyl-2'-acetonaphthone or 7-acetyl-6-ethyl-1,1,4,4-tetramethyl-1,2,3,4-tetrahydronaphtalen

▼M5

363. O-phenylenediamine and its salts

364. 4-methyl-m-phenylenediamine and its salts.

▼M32 —————

▼M32

365. Aristolochic acid and its salts; Aristolochia spp. and their preparations

▼M10

366. Chloroform

▼M32 —————

▼M32

367. 2,3,7,8-Tetra chlorodibenzo-p-dioxin

▼M10

368. 2,6-Dimethyl-1,3-dioxan-4-yl acetate (Dimethoxane)

369. Pyrithione sodium (INNM)

▼M12

370. N-(Trichloromethylthio)-4-cyclohexene-1,2-dicarboximide (captan)

371. 2,2'-Dihydroxy-3,3',5,5',6,6'-hexachlorodiphenylmethane (hexachlorophene)

▼M32 —————

▼M32

372. 6-(Piperidinyl)-2,4-pyrimidinediamine 3-oxide (minoxidil) and its salts

373. 3,4',5-Tribromosalicylanilide

374. Phytolacca spp. and their preparations

▼M13

375. Tretinoin (retinoic acid and its salts)

376. 1-Methoxy-2,4-diaminobenzene (2,4-diaminoanisole - CI 76050) ►M17 and their salts ◄

377. 1-Methoxy-2,5-diaminobenzene (2,5-diaminoanisole) ►M17 and their salts ◄

378. Colouring agent CI 12140

379. Colouring agent CI 26105

380. Colouring agent CI 42555 Colouring agent CI 42555-1 Colouring agent CI 42555-2

▼M15

381. Amyl 4-dimethylaminobenzoate, mixed isomers (Padimate A (INN))

▼M39 —————

▼M15

383. 2-Amino.4-nitrophenol

384. 2-Amino-5-nitrophenol

▼M17

385. 11 α-Hydroxypregn-4-ene-3,20-dione and its esters

▼M32

385. 11α-Hydroxypregn-4-ene-3, 20-dione) and its esters

▼M32 —————

▼M32

386. Colouring agent C.I. 42 640

▼M17

387. Colouring agent CI 13 065

388. Colouring agent CI 42 535

389. Colouring agent CI 61 554

▼M32 —————

▼M32

390. Anti-androgens of steroidal structure

391. Zirconium and its compounds, with the exception of the substances listed under reference number 50 in Annex III, Part One, and the zirconium lakes, pigments or salts of the colouring agents listed in Annex IV, Part One, with reference number 3

393. Acetonitrile

394. Tetrahydrozoline and its salts

▼M18

395. Hydroxy-8-quinoline and its sulphate, except for the uses provided for in No 51 in Annex III, Part 1

396. Dithio-2,2-bispyridine-dioxide 1,1' (additive with trihydrated magnesium sulphate) - (pyrithione disulphide + magnesium sulphate)

397. Colouring agent CI 12075 and its lakes, pigments and salts

398. Colouring agent CI 45170 and CI 45170:1

399. Lidocaine

▼M20

400. 1,2-epoxybutane

401. Colouring agent CI 15585

402. Strontium lactate

403. Strontium nitrate

404. Strontium polycarboxylate

405. Pramocaine

406. 4-ethoxy-m-phenylenediamine and its salts

407. 2,4-diaminophenylethanol and its salts

408. Catechol

409. Pyrogallol

410. Nitrosamines

▼M39

411. Secondary alkyl- and alkanolamines and their salts

▼M22

412. 4-Amino-2-nitrophenol

▼M23

413. 2-Methyl-m-phenylenediamine

▼M24

414. 4-tert-Butyl-3-methoxy-2,6-dinitrotoluene (Musk Ambrette)

▼M28 —————

▼M24

416. Cells, tissues or products of human origin

417. 3,3-Bis(4-hydroxyphenyl)phthalide (Phenolphthalein*)

▼M25

418. 3-Imidazol-4-ylacrylic acid and its ethyl ester (urocanic acid)

▼M29

419. ►M35 From the date referred to in Article 22(1) of Regulation (EC) No 999/2001 of the European Parliament and of the Council ( 9 ), the specified risk materials as designated in Annex V to that Regulation, and ingredients derived therefrom. Until that date, the specified risk materials as designated in Annex XI Part A to Regulation (EC) No 999/2001, and ingredients derived therefrom. However, tallow derivatives may be used provided that the following methods have been used and strictly certified by the producer: ▼M31 — Transesterification or hydrolysis at at least 200 °C and at an appropriate corresponding pressure, for 20 minutes (glycerol, fatty acids and fatty acid esters), ▼M29 — Saponification with NaOH 12M (glycerol and soap): — — Batch process: at 95 °C for three hours — or — Continuous process: at 140 °C, two bars (2 000 hPa) for eight minutes or equivalent conditions.

▼M28

420. Crude and refined coal tars

▼M30

421. 1,1,3,3,5,-Pentamethyl-4,6-dinitroindane (moskene)

422. 5-tert-Butyl-1,2,3-trimethyl-4,6-dinitrobenzene (musk tibetene).

▼M34

423. Alanroot oil (Inula helenium) (CAS No 97676-35-2), when used as a fragrance ingredient.

424. Benzyl cyanide (CAS No 140-29-4), when used as a fragrance ingredient.

425. Cyclamen alcohol (CAS No 4756-19-8), when used as a fragrance ingredient.

426. Diethyl maleate (CAS No 141-05-9), when used as a fragrance ingredient.

427. Dihydrocoumarine (CAS No 119-84-6), when used as a fragrance ingredient.

428. 2,4-Dihydroxy-3-methylbenzaldehyde (CAS No 6248-20-0), when used as a fragrance ingredient.

429. 3,7-Dimethyl-2-octen-1-ol (6,7-Dihydrogeraniol) (CAS No 40607-48-5), when used as a fragrance ingredient.

430. 4,6-Dimethyl-8-tert-butylcoumarin (CAS No 17874-34-9), when used as a fragrance ingredient.

431. Dimethyl citraconate (CAS No 617-54-9), when used as a fragrance ingredient.

432. 7,11-Dimethyl-4,6,10-dodecatrien-3-one (CAS No 26651-96-7), when used as a fragrance ingredient.

433. 6,10-Dimethyl-3,5,9-undecatrien-2-one (CAS No 141-10-6), when used as a fragrance ingredient.

434. Diphenylamine (CAS No 122-39-4), when used as a fragrance ingredient.

435. Ethyl acrylate (CAS No 140-88-5), when used as a fragrance ingredient.

436. Fig leaf absolute (Ficus carica) (CAS No 68916-52-9), when used as a fragrance ingredient.

437. trans-2-Heptenal (CAS No 18829-55-5), when used as a fragrance ingredient.

438. trans-2-Hexenal diethyl acetal (CAS No 67746-30-9), when used as a fragrance ingredient.

439. trans-2-Hexenal dimethyl acetal (CAS No 18318-83-7), when used as a fragrance ingredient.

440. Hydroabietyl alcohol (CAS No 13393-93-6), when used as a fragrance ingredient.

441. 6-Isopropyl-2-decahydronaphthalenol (CAS No 34131-99-2), when used as a fragrance ingredient.

442. 7-Methoxycoumarin (CAS No 531-59-9), when used as a fragrance ingredient.

443. 4-(4-Methoxyphenyl)-3-butene-2-one (CAS No 943-88-4), when used as a fragrance ingredient.

444. 1-(4-Methoxyphenyl)-1-penten-3-one (CAS No 104-27-8), when used as a fragrance ingredient.

445. Methyl trans-2-butenoate (CAS No 623-43-8), when used as a fragrance ingredient.

446. 7-Methylcoumarin (CAS No 2445-83-2), when used as a fragrance ingredient.

447. 5-Methyl-2,3-hexanedione (CAS No 13706-86-0), when used as a fragrance ingredient.

448. 2-Pentylidenecyclohexanone (CAS No 25677-40-1), when used as a fragrance ingredient.

449. 3,6,10-Trimethyl-3,5,9-undecatrien-2-one (CAS No 1117-41-5), when used as a fragrance ingredient.

450. Verbena oil (Lippia citriodora Kunth.) (CAS No 8024-12-2), when used as a fragrance ingredient.

►C5 451. Methyleugenol (CAS No 93-15-2) ◄ except for normal content in the natural essences used and provided that the concentration does not exceed: (a) 0,01 % in fine fragrance (b) 0,004 % in eau de toilette (c) 0,002 % in fragrance cream (d) 0,001 % in rinse-off products (e) 0,0002 % in other leave-on products and oral hygiene products.

▼M43

452. 6-(2-Chloroethyl)-6-(2-methoxyethoxy)-2,5,7,10-tetraoxa-6-silaundecane (Cas No. 37894-46-5)

453. Cobalt dichloride (Cas No. 7646-79-9)

454. Cobalt sulphate (Cas No 10124-43-3)

455. Nickel monoxide (Cas No 1313-99-1)

456. Dinickel trioxide (Cas No 1314-06-3)

457. Nickel dioxide (Cas No 12035-36-8)

458. Trinickel disulphide (Cas No 12035-72-2)

459. Tetracarbonylnickel (Cas No 13463-39-3)

460. Nickel sulphide (Cas No 16812-54-7)

461. Potassium bromate (Cas No 7758-01-2)

462. Carbon monoxide (Cas No 630-08-0)

463. Buta-1,3-diene (Cas No 106-99-0)

464. Isobutane (Cas No 75-28-5), if it contains ≥ 0,1 % w/w Butadiene

465. Butane (Cas No 106-97-8), if it contains ≥ 0,1 % w/w Butadiene

466. Gases (petroleum), C3-4 (Cas No 68131-75-9), if they contain > 0,1 % w/w Butadiene

467. Tail gas (petroleum), catalytic cracked distillate and catalytic cracked naphtha fractionation absorber (Cas No 68307-98-2), if it contains > 0,1 % w/w Butadiene

468. Tail gas (petroleum), catalytic polymn. naphtha fractionation stabiliser (Cas No 68307-99-3), if it contains > 0,1 % w/w Butadiene

469. Tail gas (petroleum), catalytic reformed naphtha fractionation stabiliser, hydrogen sulfide-free (Cas No 68308-00-9), if it contains > 0,1 % w/w Butadiene

470. Tail gas (petroleum), cracked distillate hydrotreater stripper (Cas No 68308-01-0), if it contains > 0,1 % w/w Butadiene

471. Tail gas (petroleum), gas oil catalytic cracking absorber (Cas No 68308-03-2), if it contains > 0,1 % w/w Butadiene

472. Tail gas (petroleum), gas recovery plant (Cas No 68308-04-3), if it contains > 0,1 % w/w Butadiene

473. Tail gas (petroleum), gas recovery plant deethaniser (Cas No 68308-05-4), if it contains > 0,1 % w/w Butadiene

474. Tail gas (petroleum), hydrodesulfurised distillate and hydrodesulfurised naphtha fractionator, acid-free (Cas No 68308-06-5), if it contains > 0,1 % w/w Butadiene

475. Tail gas (petroleum), hydrodesulfurised vacuum gas oil stripper, hydrogen sulfide-free (Cas No 68308-07-6), if it contains > 0,1 % w/w Butadiene

476. Tail gas (petroleum), isomerised naphtha fractionation stabiliser (Cas No 68308-08-7), if it contains > 0,1 % w/w Butadiene

477. Tail gas (petroleum), light straight-run naphtha stabiliser, hydrogen sulfide-free (Cas No 68308-09-8), if it contains > 0,1 % w/w Butadiene

478. Tail gas (petroleum), straight-run distillate hydrodesulferised, hydrogen sulfide-free (Cas No 68308-10-1), if it contains > 0,1 % w/w Butadiene

479. Tail gas (petroleum), propane-propylene alkylation feed prep deethaniser (Cas No 68308-11-2), if it contains > 0,1 % w/w Butadiene

480. Tail gas (petroleum), vacuum gas oil hydrodesulferised, hydrogen sulfide-free (Cas No 68308-12-3), if it contains > 0,1 % w/w Butadiene

481. Gases (petroleum), catalytic cracked overheads (Cas No 68409-99-4), if they contain > 0,1 % w/w Butadiene

482. Alkanes, C1-2 (Cas No 68475-57-0), if they contain > 0,1 % w/w Butadiene

483. Alkanes, C2-3 (Cas No 68475-58-1), if they contain > 0,1 % w/w Butadiene

484. Alkanes, C3-4 (Cas No 68475-59-2), if they contain > 0,1 % w/w Butadiene

485. Alkanes, C4-5 (Cas No 68475-60-5), if they contain > 0,1 % w/w Butadiene

486. Fuel-gases (Cas No 68476-26-6), if they contain > 0,1 % w/w Butadiene

487. Fuel gases, crude oil distillates (Cas No 68476-29-9), if they contain > 0,1 % w/w Butadiene

488. Hydrocarbons, C3-4 (Cas No 68476-40-4), if they contain > 0,1 % w/w Butadiene

489. Hydrocarbons, C4-5 (Cas No 68476-42-6), if they contain > 0,1 % w/w Butadiene

490. Hydrocarbons, C2-4, C3-rich (Cas No 68476-49-3), if they contain > 0,1 % w/w Butadiene

491. Petroleum gases, liquefied (Cas No 68476-85-7), if they contain > 0,1 % w/w Butadiene

492. Petroleum gases, liquefied, sweetened (Cas No 68476-86-8), if they contain > 0,1 % w/w Butadiene

493. Gases (petroleum), C3-4, isobutane-rich (Cas No 68477-33-8), if they contain > 0,1 % w/w Butadiene

494. Distillates (petroleum), C3-6, piperylene-rich (Cas No 68477-35-0), if they contain > 0,1 % w/w Butadiene

495. Gases (petroleum), amine system feed (Cas No 68477-65-6), if they contain > 0,1 % w/w Butadiene

496. Gases (petroleum), benzene unit hydrodesulferised off (Cas No 68477-66-7), if they contain > 0,1 % w/w Butadiene

497. Gases (petroleum), benzene unit recycle, hydrogen-rich (Cas No 68477-67-8), if they contain > 0,1 % w/w Butadiene

498. Gases (petroleum), blend oil, hydrogen-nitrogen-rich (Cas No 68477-68-9), if they contain > 0,1 % w/w Butadiene

499. Gases (petroleum), butane splitter overheads (Cas No 68477-69-0), if they contain > 0,1 % w/w Butadiene

500. Gases (petroleum), C2-3 (Cas No 68477-70-3), if they contain > 0,1 % w/w Butadiene

501. Gases (petroleum), catalytic-cracked gas oil depropaniser bottoms, C4-rich acid-free (Cas No 68477-71-4), if they contain > 0,1 % w/w Butadiene

502. Gases (petroleum), catalytic-cracked naphtha debutaniser bottoms, C3-5-rich (Cas No 68477-72-5), if they contain > 0,1 % w/w Butadiene

503. Gases (petroleum), catalytic cracked naphtha depropaniser overhead, C3-rich acid-free (Cas No 68477-73-6), if they contain > 0,1 % w/w Butadiene

504. Gases (petroleum), catalytic cracker (Cas No 68477-74-7), if they contain > 0,1 % w/w Butadiene

505. Gases (petroleum), catalytic cracker, C1-5-rich (Cas No 68477-75-8), if they contain > 0,1 % w/w Butadiene

506. Gases (petroleum), catalytic polymd. naphtha stabiliser overhead, C2-4-rich (Cas No 68477-76-9), if they contain > 0,1 % w/w Butadiene

507. Gases (petroleum), catalytic reformed naphtha stripper overheads (Cas No 68477-77-0), if they contain > 0,1 % w/w Butadiene

508. Gases (petroleum), catalytic reformer, C1-4-rich (Cas No 68477-79-2), if they contain > 0,1 % w/w Butadiene

509. Gases (petroleum), C6-8 catalytic reformer recycle (Cas No 68477-80-5), if they contain > 0,1 % w/w Butadiene

510. Gases (petroleum), C6-8 catalytic reformer (Cas No 68477-81-6), if they contain > 0,1 % w/w Butadiene

511. Gases (petroleum), C6-8 catalytic reformer recycle, hydrogen-rich (Cas No 68477-82-7), if they contain > 0,1 % w/w Butadiene

512. Gases (petroleum), C3-5 olefinic-paraffinic alkylation feed (Cas No 68477-83-8), if they contain > 0,1 % w/w Butadiene

513. Gases (petroleum), C2-return stream (Cas No 68477-84-9), if they contain > 0,1 % w/w Butadiene

514. Gases (petroleum), C4-rich (Cas No 68477-85-0), if they contain > 0,1 % w/w Butadiene

515. Gases (petroleum), deethaniser overheads (Cas No 68477-86-1), if they contain > 0,1 % w/w Butadiene

516. Gases (petroleum), deisobutaniser tower overheads (Cas No 68477-87-2), if they contain > 0,1 % w/w Butadiene

517. Gases (petroleum), depropaniser dry, propene-rich (Cas No 68477-90-7), if they contain > 0,1 % w/w Butadiene

518. Gases (petroleum), depropaniser overheads (Cas No 68477-91-8), if they contain > 0,1 % w/w Butadiene

519. Gases (petroleum), dry sour, gas-concn.-unit-off (Cas No 68477-92-9), if they contain > 0,1 % w/w Butadiene

520. Gases (petroleum), gas concn. reabsorber distn. (Cas No 68477-93-0), if they contain > 0,1 % w/w Butadiene

521. Gases (petroleum), gas recovery plant depropaniser overheads (Cas No 68477-94-1), if they contain > 0,1 % w/w Butadiene

522. Gases (petroleum), Girbatol unit feed (Cas No 68477-95-2), if they contain > 0,1 % w/w Butadiene

523. Gases (petroleum), hydrogen absorber off (Cas No 68477-96-3), if they contain > 0,1 % w/w Butadiene

524. Gases (petroleum), hydrogen-rich (Cas No 68477-97-4), if they contain > 0,1 % w/w Butadiene

525. Gases (petroleum), hydrotreater blend oil recycle, hydrogen-nitrogen-rich (Cas No 68477-98-5), if they contain > 0,1 % w/w Butadiene

526. Gases (petroleum), isomerised naphtha fractionator, C4-rich, hydrogen sulfide-free (Cas No 68477-99-6), if they contain > 0,1 % w/w Butadiene

527. Gases (petroleum), recycle, hydrogen-rich (Cas No 68478-00-2), if they contain > 0,1 % w/w Butadiene

528. Gases (petroleum), reformer make-up, hydrogen-rich (Cas No 68478-01-3), if they contain > 0,1 % w/w Butadiene

529. Gases (petroleum), reforming hydrotreater (Cas No 68478-02-4), if they contain > 0,1 % w/w Butadiene

530. Gases (petroleum), reforming hydrotreater, hydrogen-methane-rich (Cas No 68478-03-5), if they contain > 0,1 % w/w Butadiene

531. Gases (petroleum), reforming hydrotreater make-up, hydrogen-rich (Cas No 68478-04-6), if they contain > 0,1 % w/w Butadiene

532. Gases (petroleum), thermal cracking distn. (Cas No 68478-05-7), if they contain > 0,1 % w/w Butadiene

533. Tail gas (petroleum), catalytic cracked clarified oil and thermal cracked vacuum residue fractionation reflux drum (Cas No 68478-21-7), if it contains > 0,1 % w/w Butadiene

534. Tail gas (petroleum), catalytic cracked naphtha stabilisation absorber (Cas No 68478-22-8), if it contains > 0,1 % w/w Butadiene

535. Tail gas (petroleum), catalytic cracker, catalytic reformer and hydrodesulferised combined fractionater (Cas No 68478-24-0), if it contains > 0,1 % w/w Butadiene

536. Tail gas (petroleum), catalytic cracker refractionation absorber (Cas No 68478-25-1), if it contains > 0,1 % w/w Butadiene

537. Tail gas (petroleum), catalytic reformed naphtha fractionation stabiliser (Cas No 68478-26-2), if it contains > 0,1 % w/w Butadiene

538. Tail gas (petroleum), catalytic reformed naphtha separator (Cas No 68478-27-3), if it contains > 0,1 % w/w Butadiene

539. Tail gas (petroleum), catalytic reformed naphtha stabiliser (Cas No 68478-28-4), if it contains > 0,1 % w/w Butadiene

540. Tail gas (petroleum), cracked distillate hydrotreater separator (Cas No 68478-29-5), if it contains > 0,1 % w/w Butadiene

541. Tail gas (petroleum), hydrodesulfurised straight-run naphtha separator (Cas No 68478-30-8), if it contains > 0,1 % w/w Butadiene

542. Tail gas (petroleum), saturate gas plant mixed stream, C4-rich (Cas No 68478-32-0), if it contains > 0,1 % w/w Butadiene

543. Tail gas (petroleum), saturate gas recovery plant, C1-2-rich (Cas No 68478-33-1), if it contains > 0,1 % w/w Butadiene

544. Tail gas (petroleum), vacuum residues thermal cracker (Cas No 68478-34-2), if it contains > 0,1 % w/w Butadiene

545. Hydrocarbons, C3-4-rich, petroleum distillate (Cas No 68512-91-4), if they contain > 0,1 % w/w Butadiene

546. Gases (petroleum), catalytic reformed straight-run naphtha stabiliser overheads (Cas No 68513-14-4), if they contain > 0,1 % w/w Butadiene

547. Gases (petroleum), full-range straight-run naphtha dehexaniser off (Cas No 68513-15-5), if they contain > 0,1 % w/w Butadiene

548. Gases (petroleum), hydrocracking depropaniser off, hydrocarbon-rich (Cas No 68513-16-6), if they contain > 0,1 % w/w Butadiene

549. Gases (petroleum), light straight-run naphtha stabiliser off (Cas No 68513-17-7), if they contain > 0,1 % w/w Butadiene

550. Gases (petroleum), reformer effluent high-pressure flash drum off (Cas No 68513-18-8), if they contain > 0,1 % w/w Butadiene

551. Gases (petroleum), reformer effluent low-pressure flash drum off (Cas No 68513-19-9), if they contain > 0,1 % w/w Butadiene

552. Residues (petroleum), alkylation splitter, C4-rich (Cas No 68513-66-6), if they contain > 0,1 % w/w Butadiene

553. Hydrocarbons, C1-4 (Cas No 68514-31-8), if they contain > 0,1 % w/w Butadiene

554. Hydrocarbons, C1-4, sweetened (Cas No 68514-36-3), if they contain > 0,1 % w/w Butadiene

555. Gases (petroleum), oil refinery gas distn. off (Cas No 68527-15-1), if they contain > 0,1 % w/w Butadiene

556. Hydrocarbons, C1-3 (Cas No 68527-16-2), if they contain > 0,1 % w/w Butadiene

557. Hydrocarbons, C1-4, debutanizer fraction (Cas No 68527-19-5), if they contain > 0,1 % w/w Butadiene

558. Gases (petroleum), benzene unit hydrotreater depentaniser overheads (Cas No 68602-82-4), if they contain > 0,1 % w/w Butadiene

559. Gases (petroleum), C1-5, wet (Cas No 68602-83-5), if they contain > 0,1 % w/w Butadiene

560. Gases (petroleum), secondary absorber off, fluidised catalytic cracker overheads fractionator (Cas No 68602-84-6), if they contain > 0,1 % w/w Butadiene

561. Hydrocarbons, C2-4 (Cas No 68606-25-7), if they contain > 0,1 % w/w Butadiene

562. Hydrocarbons, C3 (Cas No 68606-26-8), if they contain > 0,1 % w/w Butadiene

563. Gases (petroleum), alkylation feed (Cas No 68606-27-9), if they contain > 0,1 % w/w Butadiene

564. Gases (petroleum), depropaniser bottoms fractionation off (Cas No 68606-34-8), if they contain > 0,1 % w/w Butadiene

565. Petroleum products, refinery gases (Cas No 68607-11-4), if they contain > 0,1 % w/w Butadiene

566. Gases (petroleum), hydrocracking low-pressure separator (Cas No 68783-06-2), if they contain > 0,1 % w/w Butadiene

567. Gases (petroleum), refinery blend (Cas No 68783-07-3), if they contain > 0,1 % w/w Butadiene

568. Gases (petroleum), catalytic cracking (Cas No 68783-64-2), if they contain > 0,1 % w/w Butadiene

569. Gases (petroleum), C2-4, sweetened (Cas No 68783-65-3), if they contain > 0,1 % w/w Butadiene

570. Gases (petroleum), refinery (Cas No 68814-67-5), if they contain > 0,1 % w/w Butadiene

571. Gases (petroleum), platformer products separator off (Cas No 68814-90-4), if they contain > 0,1 % w/w Butadiene

572. Gases (petroleum), hydrotreated sour kerosine depentaniser stabiliser off (Cas No 68911-58-0), if they contain > 0,1 % w/w Butadiene

573. Gases (petroleum), hydrotreated sour kerosine flash drum (Cas No 68911-59-1), if they contain > 0,1 % w/w Butadiene

574. Gases (petroleum), crude oil fractionation off (Cas No 68918-99-0), if they contain > 0,1 % w/w Butadiene

575. Gases (petroleum), dehexaniser off (Cas No 68919-00-6), if they contain > 0,1 % w/w Butadiene

576. Gases (petroleum), distillate unifiner desulfurisation tripper off (Cas No 68919-01-7), if they contain > 0,1 % w/w Butadiene

577. Gases (petroleum), fluidised catalytic cracker fractionation off (Cas No 68919-02-8) if they contain > 0,1 % w/w Butadiene

578. Gases (petroleum), fluidised catalytic cracker scrubbing secondary absorber off (Cas No 68919-03-9), if they contain > 0,1 % w/w Butadiene

579. Gases (petroleum), heavy distillate hydrotreater desulfurisation stripper off (Cas No 68919-04-0), if they contain > 0,1 % w/w Butadiene

580. Gases (petroleum), light straight run gasoline fractionation stabiliser off (Cas No 68919-05-1), if they contain > 0,1 % w/w Butadiene

581. Gases (petroleum), naphtha unifiner desulfurisation stripper off (Cas No 68919-06-2), if they contain > 0,1 % w/w Butadiene

582. Gases (petroleum), platformer stabiliser off, light ends fractionation (Cas No 68919-07-3), if they contain > 0,1 % w/w Butadiene

583. Gases (petroleum), preflash tower off, crude distn. (Cas No 68919-08-4), if they contain > 0,1 % w/w Butadiene

584. Gases (petroleum), straight-run naphtha catalytic reforming off (Cas No 68919-09-5), if they contain > 0,1 % w/w Butadiene

585. Gases (petroleum), straight-run stabiliser off (Cas No 68919-10-8), if they contain > 0,1 % w/w Butadiene

586. Gases (petroleum), tar stripper off (Cas No 68919-11-9), if they contain > 0,1 % w/w Butadiene

587. Gases (petroleum), unifiner stripper off (Cas No 68919-12-0), if they contain > 0,1 % w/w Butadiene

588. Gases (petroleum), fluidised catalytic cracker splitter overheads (Cas No 68919-20-0), if they contain > 0,1 % w/w Butadiene

589. Gases (petroleum), catalytic cracked naphtha debutanizer (Cas No 68952-76-1), if they contain > 0,1 % w/w Butadiene

590. Tail gas (petroleum), catalytic cracked distillate and naphtha stabiliser (Cas No 68952-77-2), if it contains > 0,1 % w/w Butadiene

591. Tail gas (petroleum), catalytic hydrodesulfurised naphtha separator (Cas No 68952-79-4), if it contains > 0,1 % w/w Butadiene

592. Tail gas (petroleum), straight-run naphtha hydrodesulferised (Cas No 68952-80-7), if it contains > 0,1 % w/w Butadiene

593. Tail gas (petroleum), thermal-cracked distillate, gas oil and naphtha absorber (Cas No 68952-81-8), if it contains > 0,1 % w/w Butadiene

594. Tail gas (petroleum), thermal cracked hydrocarbon fractionation stabiliser, petroleum coking (Cas No 68952-82-9), if it contains > 0,1 % w/w Butadiene

595. Gases (petroleum), light steam-cracked, butadiene conc. (Cas No 68955-28-2), if they contain > 0,1 % w/w Butadiene

596. Gases (petroleum), sponge absorber off, fluidised catalytic cracker and gas oil desulfuriser overhead fractionation (Cas No 68955-33-9), if they contain > 0,1 % w/w Butadiene

597. Gases (petroleum), straight-run naphtha catalytic reformer stabiliser overhead (Cas No 68955-34-0), if they contain > 0,1 % w/w Butadiene

598. Gases (petroleum), crude distn. and catalytic cracking (Cas No 68989-88-8), if they contain > 0,1 % w/w Butadiene

599. Hydrocarbons, C4 (Cas No 87741-01-3), if they contain > 0,1 % w/w Butadiene

600. Alkanes, C1-4, C3-rich (Cas No 90622-55-2), if they contain > 0,1 % w/w Butadiene

601. Gases (petroleum), gas oil diethanolamine scrubber off (Cas No 92045-15-3), if they contain > 0,1 % w/w Butadiene

602. Gases (petroleum), gas oil hydrodesulfurisation effluent (Cas No 92045-16-4), if they contain > 0,1 % w/w Butadiene

603. Gases (petroleum), gas oil hydrodesulfurisation purge (Cas No 92045-17-5), if they contain > 0,1 % w/w Butadiene

604. Gases (petroleum), hydrogenator effluent flash drum off (Cas No 92045-18-6), if they contain > 0,1 % w/w Butadiene

605. Gases (petroleum), naphtha steam cracking high-pressure residual (Cas No 92045-19-7), if they contain > 0,1 % w/w Butadiene

606. Gases (petroleum), residue visbreaking off (Cas No 92045-20-0), if they contain > 0,1 % w/w Butadiene

607. Gases (petroleum), steam-cracker C3-rich (Cas No 92045-22-2), if they contain > 0,1 % w/w Butadiene

608. Hydrocarbons, C4, steam-cracker distillate (Cas No 92045-23-3), if they contain > 0,1 % w/w Butadiene

609. Petroleum gases, liquefied, sweetened, C4 fraction (Cas No 92045-80-2), if they contain > 0,1 % w/w Butadiene

610. Hydrocarbons, C4, 1,3-butadiene- and isobutene-free (Cas No 95465-89-7), if they contain > 0,1 % w/w Butadiene

611. Raffinates (petroleum), steam-cracked C4 fraction cuprous ammonium acetate extn., C3-5 and C3-5 unsatd., butadiene-free (Cas No 97722-19-5), if they contain > 0,1 % w/w Butadiene

612. Benzo[def]chrysene (=benzo[a]pyrene) (Cas No 50-32-8)

613. Pitch, coal tar-petroleum (Cas No 68187-57-5), if it contains > 0,005 % w/w benzo[a]pyrene

614. Distillates (coal-petroleum), condensed-ring arom. (Cas No 68188-48-7), if they contain > 0,005 % w/w benzo[a]pyrene

615. Distillates (coal tar), upper, fluorene-free (Cas No 84989-10-6), if they contain > 0,005 % w/w benzo[a]pyrene

616. Distillates (coal tar), upper, fluorene-rich (Cas No 84989-11-7), if they contain > 0,005 % w/w benzo[a]pyrene

617. Creosote oil, acenaphthene fraction, acenaphthene-free (Cas No 90640-85-0), if it contains > 0,005 % w/w benzo[a]pyrene

618. Pitch, coal tar, low-temp. (Cas No 90669-57-1), if it contains > 0,005 % w/w benzo[a]pyrene

619. Pitch, coal tar, low-temp., heat-treated (Cas No 90669-58-2), if it contains > 0,005 % w/w benzo[a]pyrene

620. Pitch, coal tar, low-temp., oxidised (Cas No 90669-59-3), if it contains > 0,005 % w/w benzo[a]pyrene

621. Extract residues (coal), brown (Cas No 91697-23-3), if they contain > 0,005 % w/w benzo[a]pyrene

622. Paraffin waxes (coal), brown-coal high-temp. tar (Cas No 92045-71-1), if they contain > 0,005 % w/w benzo[a]pyrene

623. Paraffin waxes (coal), brown-coal high-temp. tar, hydrotreated (Cas No 92045-72-2), if they contain > 0,005 % w/w benzo[a]pyrene

624. Waste solids, coal-tar pitch coking (Cas No 92062-34-5), if they contain > 0,005 % w/w benzo[a]pyrene

625. Pitch, coal tar, high-temp., secondary (Cas No 94114-13-3), if it contains > 0,005 % w/w benzo[a]pyrene

626. Residues (coal), liq. solvent extn. (Cas No 94114-46-2), if they contain > 0,005 % w/w benzo[a]pyrene

627. Coal liquids, liq. solvent extn. soln. (Cas No 94114-47-3), if they contain > 0,005 % w/w benzo[a]pyrene

628. Coal liquids, liq. solvent extn. (Cas No 94114-48-4), if they contain > 0,005 % w/w benzo[a]pyrene

629. Paraffin waxes (coal), brown-coal high-temp. tar, carbon-treated (Cas No 97926-76-6), if they contain > 0,005 % w/w benzo[a]pyrene

630. Paraffin waxes (coal), brown-coal high-temp tar, clay-treated (Cas No 97926-77-7), if they contain > 0,005 % w/w benzo[a]pyrene

631. Paraffin waxes (coal), brown-coal high-temp tar, silicic acid-treated (Cas No 97926-78-8), if they contain > 0,005 % w/w benzo[a]pyrene

632. Absorption oils, bicyclo arom. and heterocylic hydrocarbon fraction (Cas No 101316-45-4), if they contain > 0,005 % w/w benzo[a]pyrene

633. Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene polypropylene pyrolysis-derived (Cas No 101794-74-5), if they contain > 0,005 % w/w benzo[a]pyrene

634. Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene pyrolysis-derived (Cas No 101794-75-6), if they contain > 0,005 % w/w benzo[a]pyrene

635. Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polystyrene pyrolysis-derived (Cas No 101794-76-7), if they contain > 0,005 % w/w benzo[a]pyrene

636. Pitch, coal tar, high-temp., heat-treated (Cas No 121575-60-8), if it contains > 0,005 % w/w benzo[a]pyrene

637. Dibenz[a,h]anthracene (Cas No 53-70-3)

638. Benz[a]anthracene (Cas No 56-55-3)

639. Benzo[e]pyrene (Cas No 192-97-2)

640. Benzo[j]fluoranthene (Cas No 205-82-3)

641. Benz(e)acephenanthrylene (Cas No 205-99-2)

642. Benzo(k)fluoranthene (Cas No 207-08-9)

643. Chrysene (Cas No 218-01-9)

644. 2-Bromopropane (Cas No 75-26-3)

645. Trichloroethylene (Cas No 79-01-6)

646. 1,2-Dibromo-3-chloropropane (Cas No 96-12-8)

647. 2,3-Dibromopropan-1-ol (Cas No 96-13-9)

648. 1,3-Dichloropropan-2-ol (Cas No 96-23-1)

649. α,α,α-Trichlorotoluene (Cas No 98-07-7)

650. α-Chlorotoluene (Cas No 100-44-7)

651. 1,2-Dibromoethane (Cas No 106-93-4)

652. Hexachlorobenzene (Cas No 118-74-1)

653. Bromoethylene (Cas No 593-60-2)

654. 1,4-Dichlorobut-2-ene (Cas No 764-41-0)

655. Methyloxirane (Cas No 75-56-9)

656. (Epoxyethyl)benzene (Cas No 96-09-3)

657. 1-Chloro-2,3-epoxypropane (Cas No 106-89-8)

658. R-1-Chloro-2,3-epoxypropane (Cas No 51594-55-9)

659. 1,2-Epoxy-3-phenoxypropane (Cas No 122-60-1)

660. 2,3-Epoxypropan-1-ol (Cas No 556-52-5)

661. R-2,3-Epoxy-1-propanol (Cas No 57044-25-4)

662. 2,2′-Bioxirane (Cas No 1464-53-5)

664. Chloromethyl methyl ether (Cas No 107-30-2)

665. 2-Methoxyethanol (Cas No 109-86-4)

666. 2-Ethoxyethanol (Cas No 110-80-5)

667. Oxybis[chloromethane], bis (Chloromethyl) ether (Cas No 542-88-1)

668. 2-Methoxypropanol (Cas No 1589-47-5)

669. Propiolactone (Cas No 57-57-8)

670. Dimethylcarbamoyl chloride (Cas No 79-44-7)

671. Urethane (Cas No 51-79-6)

672. 2-Methoxyethyl acetate (Cas No 110-49-6)

673. 2-Ethoxyethyl acetate (Cas No 111-15-9)

674. Methoxyacetic acid (Cas No 625-45-6)

675. Dibutyl phthalate (Cas No 84-74-2)

676. bis(2-Methyoxyethyl) ether (Cas No 111-96-6)

677. bis(2-Ethylhexyl) phthalate (Cas No 117-81-7)

678. bis(2-Methoxyethyl) phthalate (Cas No 117-82-8)

679. 2-Methoxypropyl acetate (Cas No 70657-70-4)

680. 2-Ethylhexyl[[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-methyl]thio]acetate (Cas No 80387-97-9)

681. Acrylamide, unless regulated elsewhere in this Directive (Cas No 79-06-1)

682. Acrylonitrile (Cas No 107-13-1)

683. 2-Nitropropane (Cas No 79-46-9)

684. Dinoseb (Cas No 88-85-7), its salts and esters with the exception of those specified elsewhere in this list

685. 2-Nitroanisole (Cas No 91-23-6)

686. 4-Nitrobiphenyl (Cas No 92-93-3)

687. 2,4-Dinitrotoluene (Cas No 121-14-2)

688. Binapacryl (Cas No 485-31-4)

689. 2-Nitronaphthalene (Cas No 581-89-5)

690. 2,3-Dinitrotoluene (Cas No 602-01-7)

691. 5-Nitroacenaphthene (Cas No 602-87-9)

692. 2,6-Dinitrotoluene (Cas No 606-20-2)

693. 3,4-Dinitrotoluene (Cas No 610-39-9)

694. 3,5-Dinitrotoluene (Cas No 618-85-9)

695. 2,5-Dinitrotoluene (Cas No 619-15-8)

696. Dinoterb (Cas No 1420-07-1), its salts and esters

697. Nitrofen (Cas No 1836-75-5)

698. Dinitrotoluene (Cas No 25321-14-6)

699. Diazomethane (Cas No 334-88-3)

700. 1,4,5,8-Tetraaminoanthraquinone (Disperse Blue 1) (Cas No 2475-45-8)

701. Dimethylnitrosoamine (Cas No 62-75-9)

702. 1-Methyl-3-nitro-1-nitrosoguanidine (Cas No 70-25-7)

703. Nitrosodipropylamine (Cas No 621-64-7)

704. 2,2′-(Nitrosoimino)bisethanol (Cas No 1116-54-7)

705. 4,4′-Methylenedianiline (Cas No 101-77-9)

706. 4,4′-(4-Iminocyclohexa-2,5-dienylidenemethylene) dianiline hydrochloride (Cas No 569-61-9)

707. 4,4′-Methylenedi-o-toluidine (Cas No 838-88-0)

708. o-Anisidine (Cas No 90-04-0)

709. 3,3′-Dimethoxybenzidine (Cas No 119-90-4)

710. Salts of o-dianisidine

711. o-Dianisidine based azo dyes

712. 3,3′-Dichlorobenzidine (Cas No 91-94-1)

713. Benzidine dihydrochloride (Cas No 531-85-1)

714. [[1,1′-Biphenyl]-4,4′-diyl]diammonium sulphate (Cas No 531-86-2)

715. 3,3′-Dichlorobenzidine dihydrochloride (Cas No 612-83-9)

716. Benzidine sulphate (Cas No 21136-70-9)

717. Benzidine acetate (Cas No 36341-27-2)

718. 3,3′-Dichlorobenzidine dihydrogen bis(sulphate) (Cas No 64969-34-2)

719. 3,3′-Dichlorobenzidine sulphate (Cas No 74332-73-3)

720. Benzidine based azo dyes

721. 4,4′-Bi-o-toluidine (Cas No 119-93-7)

722. 4,4′-Bi-o-toluidine dihydrochloride (Cas No 612-82-8)

723. [3,3′-Dimethyl[1,1′-biphenyl]-4,4′-diyl]diammonium bis(hydrogen sulphate) (Cas No 64969-36-4)

724. 4,4′-Bi-o-toluidine sulphate (Cas No 74753-18-7)

725. o-Tolidine based dyes

726. Biphenyl-4-ylamine (Cas No 92-67-1) and its salts

727. Azobenzene (Cas No 103-33-3)

728. (Methyl-ONN-azoxy)methyl acetate (Cas No 592-62-1)

729. Cycloheximide (Cas No 66-81-9)

730. 2-Methylaziridine (Cas No 75-55-8)

731. Imidazolidine-2-thione (Cas No 96-45-7)

732. Furan (Cas No 110-00-9)

733. Aziridine (Cas No 151-56-4)

734. Captafol (2425-06-1)

735. Carbadox (Cas No 6804-07-5)

736. Flumioxazin (Cas No 103361-09-7)

737. Tridemorph (Cas No 24602-86-6)

738. Vinclozolin (Cas No 50471-44-8)

739. Fluazifop-butyl (Cas No 69806-50-4)

740. Flusilazole (Cas No 85509-19-9)

741. 1,3,5-Tris(oxiranylmethyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione (Cas No 2451-62-9)

742. Thioacetamide (Cas No 62-55-5)

743. N,N-Dimethylformamide (Cas No 68-12-2)

744. Formamide (Cas No 75-12-7)

745. N-Methylacetamide (Cas No 79-16-3)

746. N-Methylformamide (Cas No 123-39-7)

747. N,N-Dimethylacetamide (Cas No 127-19-5)

748. Hexamethylphosphoric-triamide (Cas No 680-31-9)

749. Diethyl sulphate (Cas No 64-67-5)

750. Dimethyl sulphate (Cas No 77-78-1)

751. 1,3-Propanesultone (Cas No 1120-71-4)

752. Dimethylsulphamoyl-chloride (Cas No 13360-57-1)

753. Sulfallate (Cas No 95-06-7)

754. A mixture of: 4-[[bis-(4-Fluorophenyl)methylsilyl]methyl]-4H-1,2,4-triazole and 1-[[bis-(4-fluorophenyl)methylsilyl]methyl]-1H-1,2,4-triazole (EC No 403-250-2)

755. (+/–)-Tetrahydrofurfuryl –(R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenyloxy]propionate (Cas No 119738-06-6)

756. 6-Hydroxy-1-(3-Isopropoxypropyl)-4-methyl-2-oxo-5-[4-(phenylazo)phenylazo]-1,2-dihydro-3-pyridinecarbonitrile (Cas No 85136-74-9)

757. (6-(4-Hydroxy-3-(2-methoxyphenylazo)-2-sulfonato-7-naphthylamino)-1,3,5-triazine-2,4-diyl)bis[(amino-1-methylethyl)ammonium] formate (Cas No 108225-03-2)

758. Trisodium [4′-(8-acetylamino-3,6-disulfonato-2-naphthylazo)-4″-(6-benzoylamino-3-Sulfonato-2-naphthylazo)-biphenyl-1,3′,3″,1‴-tetraolato-O,O′,O″,O‴]copper(II) (EC No 413-590-3)

759. A mixture of: N-[3-Hydroxy-2-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamideand N-2,3-bis-(2-Methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide and methacrylamide and 2-methyl-N-(2-methylacryloylaminomethoxymethyl)-acrylamide and N-(2,3-dihydroxypropoxymethyl)-2-methylacrylamide (EC No 412-790-8)

760. 1,3,5-tris-[(2S and 2R)-2,3-Epoxypropyl]-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione (Cas No 59653-74-6)

761. Erionite (Cas No 12510-42-8)

762. Asbestos (Cas No 12001-28-4)

763. Petroleum (Cas No 8002-05-9)

764. Distillates (petroleum), heavy hydrocracked (Cas No 64741-76-0), if they contain > 3 % w/w DMSO extract

765. Distillates (petroleum), solvent-refined heavy paraffinic (Cas No 64741-88-4), if they contain > 3 % w/w DMSO extract

766. Distillates (petroleum), solvent-refined light paraffinic (Cas No 64741-89-5), if they contain > 3 % w/w DMSO extract

767. Residual oils (petroleum), solvent deasphalted (Cas No 64741-95-3), if they contain > 3 % w/w DMSO extract

768. Distillates (petroleum), solvent-refined heavy naphthenic (Cas No 64741-96-4), if they contain > 3 % w/w DMSO extract

769. Distillates (petroleum), solvent-refined light naphthenic (Cas No 64741-97-5), if they contain > 3 % w/w DMSO extract

770. Residual oils (petroleum), solvent-refined (Cas No 64742-01-4), if they contain > 3 % w/w DMSO extract

771. Distillates (petroleum), clay-treated heavy paraffinic (Cas No 64742-36-5), if they contain > 3 % w/w DMSO extract

772. Distillates (petroleum), clay-treated light paraffinic (Cas No 64742-37-6), if they contain > 3 % w/w DMSO extract

773. Residual oils (petroleum), clay-treated (Cas No 64742-41-2), if they contain > 3 % w/w DMSO extract

774. Distillates (petroleum), clay-treated heavy naphthenic (Cas No 64742-44-5), if they contain > 3 % w/w DMSO extract

775. Distillates (petroleum), clay-treated light naphthenic (Cas No 64742-45-6), if they contain > 3 % w/w DMSO extract

776. Distillates (petroleum), hydrotreated heavy naphthenic (Cas No 64742-52-5), if they contain > 3% w/w DMSO extract

777. Distillates (petroleum), hydrotreated light naphthenic (Cas No 64742-53-6), if they contain > 3 % w/w DMSO extract

778. Distillates (petroleum), hydrotreated heavy paraffinic (Cas No 64742-54-7), if they contain > 3 % w/w DMSO extract

779. Distillates (petroleum), hydrotreated light paraffinic (Cas No 64742-55-8), if they contain > 3 % w/w DMSO extract

780. Distillates (petroleum), solvent-dewaxed light paraffinic (Cas No 64742-56-9), if they contain > 3 % w/w DMSO extract

781. Residual oils (petroleum), hydrotreated (Cas No 64742-57-0), if they contain > 3 % w/w DMSO extract

782. Residual oils (petroleum), solvent-dewaxed (Cas No 64742-62-7), if they contain > 3 % w/w DMSO extract

783. Distillates (petroleum), solvent-dewaxed heavy naphthenic (Cas No 64742-63-8), if they contain > 3 % w/w DMSO extract

784. Distillates (petroleum), solvent-dewaxed light naphthenic (Cas No 64742-64-9), if they contain > 3 % w/w DMSO extract

785. Distillates (petroleum), solvent-dewaxed heavy paraffinic (Cas No 64742-65-0), if they contain > 3 % w/w DMSO extract

786. Foots oil (petroleum) (Cas No 64742-67-2), if it contains > 3 % w/w DMSO extract

787. Naphthenic oils (petroleum), catalytic dewaxed heavy (Cas No 64742-68-3), if they contain > 3 % w/w DMSO extract

788. Naphthenic oils (petroleum), catalytic dewaxed light (Cas No 64742-69-4), if they contain > 3 % w/w DMSO extract

789. Paraffin oils (petroleum), catalytic dewaxed heavy (Cas No 64742-70-7), if they contain > 3 % w/w DMSO extract

790. Paraffin oils (petroleum), catalytic dewaxed light (Cas No 64742-71-8), if they contain > 3 % w/w DMSO extract

791. Naphthenic oils (petroleum), complex dewaxed heavy (Cas No 64742-75-2), if they contain > 3 % w/w DMSO extract

792. Naphthenic oils (petroleum), complex dewaxed light (Cas No 64742-76-3), if they contain > 3 % w/w DMSO extract

793. Extracts (petroleum), heavy naphthenic distillate solvent, arom. conc. (Cas No 68783-00-6), if they contain > 3 % w/w DMSO extract

794. Extracts (petroleum), solvent-refined heavy paraffinic distillate solvent (Cas No 68783-04-0), if they contain > 3 % w/w DMSO extract

795. Extracts (petroleum), heavy paraffinic distillates, solvent-deasphalted (Cas No 68814-89-1), if they contain > 3 % w/w DMSO extract

796. Lubricating oils (petroleum), C20-50, hydrotreated neutral oil-based, high-viscosity (Cas No 72623-85-9), if they contain > 3 % w/w DMSO extract

797. Lubricating oils (petroleum), C15-30, hydrotreated neutral oil-based (Cas No 72623- 86-0), if they contain > 3 % w/w DMSO extract

798. Lubricating oils (petroleum), C20-50, hydrotreated neutral oil-based (Cas No 72623- 87-1), if they contain > 3 % w/w DMSO extract

799. Lubricating oils (Cas No 74869-22-0), if they contain > 3 % w/w DMSO extract

800. Distillates (petroleum), complex dewaxed heavy paraffinic (Cas No 90640-91-8), if they contain > 3 % w/w DMSO extract

801. Distillates (petroleum), complex dewaxed light paraffinic (Cas No 90640-92-9), if they contain > 3 % w/w DMSO extract

802. Distillates (petroleum), solvent dewaxed heavy paraffinic, clay-treated (Cas No 90640-94-1), if they contain > 3 % w/w DMSO extract

803. Hydrocarbons, C20-50, solvent dewaxed heavy paraffinic, hydrotreated (Cas No 90640-95-2), if they contain > 3 % w/w DMSO extract

804. Distillates (petroleum), solvent dewaxed light paraffinic, clay-treated (Cas No 90640-96-3), if they contain > 3 % w/w DMSO extract

805. Distillates (petroleum), solvent dewaxed light paraffinic, hydrotreated (Cas No 90640-97-4), if they contain > 3 % w/w DMSO extract

806. Extracts (petroleum), heavy naphthenic distillate solvent, hydrotreated (Cas No 90641-07-9), if they contain > 3 % w/w DMSO extract

807. Extracts (petroleum), heavy paraffinic distillate solvent, hydrotreated (Cas No 90641-08-0), if they contain > 3 % w/w DMSO extract

808. Extracts (petroleum), light paraffinic distillate solvent, hydrotreated (Cas No 90641-09-1), if they contain > 3 % w/w DMSO extract

809. Residual oils (petroleum), hydrotreated solvent dewaxed (Cas No 90669-74-2), if they contain > 3 % w/w DMSO extract

810. Residual oils (petroleum), catalytic dewaxed (Cas No 91770-57-9), if they contain > 3 % w/w DMSO extract

811. Distillates (petroleum), dewaxed heavy paraffinic, hydrotreated (Cas No 91995-39-0) if they contain > 3 % w/w DMSO extract

812. Distillates (petroleum), dewaxed light paraffinic, hydrotreated (Cas No 91995-40-3), if they contain > 3 % w/w DMSO extract

813. Distillates (petroleum), hydrocracked solvent-refined, dewaxed (Cas No 91995-45-8), if they contain > 3 % w/w DMSO extract

814. Distillates (petroleum), solvent-refined light naphthenic, hydrotreated (Cas No 91995-54-9), if they contain > 3 % w/w DMSO extract

815. Extracts (petroleum), hydrotreated light paraffinic distillate solvent (Cas No 91995- 73-2), if they contain > 3 % w/w DMSO extract

816. Extracts (petroleum), light naphthenic distillate solvent, hydrodesulfurised (Cas No 91995-75-4), if they contain > 3 % w/w DMSO extract

817. Extracts (petroleum), light paraffinic distillate solvent, acid-treated (Cas No 91995-76-5), if they contain > 3 % w/w DMSO extract

818. Extracts (petroleum), light paraffinic distillate solvent, hydrodesulfurised (Cas No 91995-77-6), if they contain > 3 % w/w DMSO extract

819. Extracts (petroleum), light vacuum gas oil solvent, hydrotreated (Cas No 91995-79-8), if they contain > 3 % w/w DMSO extract

820. Foots oil (petroleum), hydrotreated (Cas No 92045-12-0), if it contains > 3 % w/w DMSO extract

821. Lubricating oils (petroleum), C17-35, solvent-extd., dewaxed, hydrotreated (Cas No 92045-42-6), if they contain > 3 % w/w DMSO extract

822. Lubricating oils (petroleum), hydrocracked nonarom solvent-deparaffined (Cas No 92045-43-7), if they contain > 3 % w/w DMSO extract

823. Residual oils (petroleum), hydrocracked acid-treated solvent-dewaxed (Cas No 92061-86-4), if they contain > 3 % w/w DMSO extract

824. Paraffin oils (petroleum), solvent-refined dewaxed heavy (Cas No 92129-09-4), if they contain > 3 % w/w DMSO extract

825. Extracts (petroleum), heavy paraffinic distillate solvent, clay-treated (Cas No 92704- 08-0), if they contain > 3 % w/w DMSO extract

826. Lubricating oils (petroleum), base oils, paraffinic (Cas No 93572-43-1), if they contain > 3 % w/w DMSO extract

827. Extracts (petroleum), heavy naphthenic distillate solvent, hydrodesulfurised (Cas No 93763-10-1), if they contain > 3 % w/w DMSO extract

828. Extracts (petroleum), solvent-dewaxed heavy paraffinic distillate solvent, hydrodesulfurised (Cas No 93763-11-2), if they contain > 3 % w/w DMSO extract

829. Hydrocarbons, hydrocracked paraffinic distn. residues, solvent-dewaxed (Cas No 93763-38-3), if they contain > 3 % w/w DMSO extract

830. Foots oil (petroleum), acid-treated (Cas No 93924-31-3), if it contains > 3 % w/w DMSO extract

831. Foots oil (petroleum), clay-treated (Cas No 93924-32-4), if it contains > 3 % w/w DMSO extract

832. Hydrocarbons, C20-50, residual oil hydrogenation vacuum distillate (Cas No 93924- 61-9), if they contain > 3 % w/w DMSO extract

833. Distillates (petroleum), solvent-refined hydrotreated heavy, hydrogenated (Cas No 94733-08-1), if they contain > 3 % w/w DMSO extract

834. Distillates (petroleum), solvent-refined hydrocracked light (Cas No 94733-09-2), if they contain > 3 % w/w DMSO extract

835. Lubricating oils (petroleum), C18-40, solvent-dewaxed hydrocracked distillate-based (Cas No 94733-15-0), if they contain > 3 % w/w DMSO extract

836. Lubricating oils (petroleum), C18-40, solvent-dewaxed hydrogenated raffinate-based (Cas No 94733-16-1), if they contain > 3 % w/w DMSO extract

837. Hydrocarbons, C13-30, arom.-rich, solvent-extd. naphthenic distillate (Cas No 95371-04-3), if they contain > 3 % w/w DMSO extract

838. Hydrocarbons, C16-32, arom. rich, solvent-extd. naphthenic distillate (Cas No 95371-05-4), if they contain > 3 % w/w DMSO extract

839. Hydrocarbons, C37-68, dewaxed deasphalted hydrotreated vacuum distn. Residues (Cas No 95371-07-6), if they contain > 3 % w/w DMSO extract

840. Hydrocarbons, C37-65, hydrotreated deasphalted vacuum distn. Residues (Cas No 95371-08-7), if they contain > 3 % w/w DMSO extract

841. Distillates (petroleum), hydrocracked solvent-refined light (Cas No 97488-73-8), if they contain > 3 % w/w DMSO extract

842. Distillates (petroleum), solvent-refined hydrogenated heavy (Cas No 97488-74-9), if they contain > 3 % w/w DMSO extract

843. Lubricating oils (petroleum), C18-27, hydrocracked solvent-dewaxed (Cas No 97488-95-4), if they contain > 3 % w/w DMSO extract

844. Hydrocarbons, C17-30, hydrotreated solvent-deasphalted atm. distn. residue, distn. lights (Cas No 97675-87-1), if they contain > 3 % w/w DMSO extract

845. Hydrocarbons, C17-40, hydrotreated solvent-deasphalted distn. residue, vacuum distn. lights (Cas No 97722-06-0), if they contain > 3 % w/w DMSO extract

846. Hydrocarbons, C13-27, solvent-extd. light naphthenic (Cas No 97722-09-3), if they contain > 3 % w/w DMSO extract

847. Hydrocarbons, C14-29, solvent-extd. light naphthenic (Cas No 97722-10-6), if they contain > 3 % w/w DMSO extract

848. Foots oil (petroleum), carbon-treated (Cas No 97862-76-5), if it contains > 3 % w/w DMSO extract

849. Foots oil (petroleum), silicic acid-treated (Cas No 97862-77-6), if it contains > 3 % w/w DMSO extract

850. Hydrocarbons, C27-42, dearomatised (Cas No 97862-81-2), if they contain > 3 % w/w DMSO extract

851. Hydrocarbons, C17-30, hydrotreated distillates, distn. Lights (Cas No 97862-82-3), if they contain > 3 % w/w DMSO extract

852. Hydrocarbons, C27-45, naphthenic vacuum distn. (Cas No 97862-83-4), if they contain > 3 % w/w DMSO extract

853. Hydrocarbons, C27-45, dearomatised (Cas No 97926-68-6), if they contain > 3 % w/w DMSO extract

854. Hydrocarbons, C20-58, hydrotreated (Cas No 97926-70-0), if they contain > 3 % w/w DMSO extract

855. Hydrocarbons, C27-42, naphthenic (Cas No 97926-71-1), if they contain > 3 % w/w DMSO extract

856. Extracts (petroleum), light paraffinic distillate solvent, carbon-treated (Cas No 100684-02-4), if they contain > 3 % w/w DMSO extract

857. Extracts (petroleum), light paraffinic distillate solvent, clay-treated (Cas No 100684- 03-5), if they contain > 3 % w/w DMSO extract

858. Extracts (petroleum), light vacuum, gas oil solvent, carbon-treated (Cas No